US20090248118A1 - Apparatus and method for determining the relative position and orientation of neurostimulation leads - Google Patents
Apparatus and method for determining the relative position and orientation of neurostimulation leads Download PDFInfo
- Publication number
- US20090248118A1 US20090248118A1 US12/476,951 US47695109A US2009248118A1 US 20090248118 A1 US20090248118 A1 US 20090248118A1 US 47695109 A US47695109 A US 47695109A US 2009248118 A1 US2009248118 A1 US 2009248118A1
- Authority
- US
- United States
- Prior art keywords
- electrode
- electrodes
- impedance
- neurostimulation leads
- orientation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
Definitions
- the present invention relates to neurostimulation systems, such as a spinal cord stimulation (SCS) system, and more particularly to a method for determining the relative position and orientation of electrodes on a neurostimulation lead or leads used with such a system.
- SCS spinal cord stimulation
- the physician places the leads in a very careful manner in order to locate the electrodes proximal to neural elements that are the target of the stimulation.
- stimulation energy is delivered to verify that the leads are indeed stimulating the appropriate neural elements.
- the leads may no longer be appropriately stimulated. At best, this can require electrical reprogramming to restore therapy or, at worst, surgical revision, where a second surgery is required and the leads must be manually readjusted.
- the physician may have only a suspicion that a lead has shifted position, based on patient reporting of paresthesia, which is not foolproof. Also, attempting to reprogram the leads based on paresthesia locations can be challenging.
- the present invention addresses the above and other needs by providing a cross-check technique for verifying the position of the electrodes of the implanted leads.
- a first technique involves the use of interelectrode impedance.
- a second technique involves measured field potentials.
- Either technique advantageously allows the relative orientation of one electrode on an implanted lead to other electrodes on the implanted lead or adjacent implanted leads in the spinal column or other body/tissue location to be readily determined.
- Such techniques are useful not only for reprogramming, but also to estimate if the shifted orientation of the electrodes is sufficiently large so as to make electrical reprogramming a waste of time, thereby suggesting that surgery may need to be performed for repositioning.
- the correct lead position may only be determined by X-ray or fluoroscopy.
- X-ray and fluoroscopy require expensive equipment, significant time, and appropriate medical facilities, most of which are not readily available.
- the relative orientation of the electrodes on the implanted leads should be known in order to allow appropriate navigation of the stimulation energy.
- a determination of the relative orientation typically requires that a fluoroscope or X-ray image of the implanted leads be present at the time of patient setup with the system programmer. Disadvantageously, however, such images may not always be available. Moreover, between the time of implant and follow-up visits, the leads may have shifted and the fluoroscope image may no longer be valid. This can result in poor patient outcomes due to inappropriate or unexpected stimulation effects during fitting.
- cross-check techniques which techniques can be used to verify the position of the leads at numerous times during the lifetime of the implanted leads, e.g., during initial implantation and programming, during followup visits, throughout the trial period, and during subsequent reprogramming sessions.
- FIG. 1 illustrates a neurostimulation system wherein two leads, each having eight in-line electrodes thereon, are positioned side-by-side, and wherein each lead is connected to an implantable pulse generator (IPG), which IPG is, in turn, coupled to an external programmer;
- IPG implantable pulse generator
- FIG. 2 shows a functional block diagram of an IPG that uses multiple programmable current sources to activate selected electrodes of the neurostimulation leads;
- FIG. 3 shows a functional block diagram of an IPG that uses multiple programmable voltage sources to activate selected electrodes of the neurostimulation leads;
- FIG. 4 is a table that contains impedance vector and distance impedance data in accordance with one embodiment of the invention.
- FIG. 5 illustrates representative relative electrode orientation in a patient having dual quadrapolar leads (two side-by-side leads, each having four in-line electrodes thereon);
- FIG. 6 is an impedance map that illustrates application of one embodiment of the invention to the electrode orientation shown in FIG. 5 ;
- FIG. 7 depicts a representative fluoroscopic image of dual quadrapolar leads in a patient
- FIG. 8 illustrates, in accordance with another embodiment of the invention, the measured electrode potential of non-activated electrodes on the dual quadrapolar lead of FIG. 7 when the activated electrode is activated through monopolar stimulation;
- FIG. 9 illustrates the measured electrode potential of non-activated electrodes on the dual quadrapolar lead of FIG. 7 when the activated electrodes are activated through tripolar stimulation.
- FIG. 10 is a flowchart that highlights the main steps used with one embodiment of the present invention.
- the present invention uses: (1) interelectrode impedance (one technique or embodiment) or (2) measured field potentials (another technique or embodiment) to determine the relative orientation of one electrode on an implanted lead to other electrodes on the implanted lead or adjacent implanted leads in the spinal column or other body/tissue location.
- FIG. 1 A representative neurostimulation system is illustrated in FIG. 1 .
- Such system may include a first implantable lead 20 and a second implantable lead 30 .
- Each lead includes a series of in-line electrodes thereon.
- the first lead 20 contains eight in-line electrodes E 1 , E 2 , E 3 , . . . E 8 .
- the second lead 30 also contains eight in-line electrodes E 9 , E 10 , E 11 , . . . E 16 .
- Each of the electrodes of each lead 20 or 30 are electrically connected through respective wires, embedded or carried within a body of the lead, to an implantable pulse generator (IPG) 40 .
- the wires connected to the electrodes E 1 , E 2 , E 3 , . . . E 8 of lead 20 may be characterized as a bundle of wires 22 that are electrically connected with the IPG 40 .
- the wires connected to the electrodes E 9 , E 10 , E 11 , . . . E 16 of lead 30 may be characterized as a bundle of wires 32 that are electrically connected with the IPG 40 .
- the IPG is able to direct electrical stimulation to selected electrodes of each lead.
- Electrode When a given electrode is selected to receive an electrical stimulus, it is (for purposes of the present invention) said to be “activated”. When an electrode is not selected to receive an electrical stimulus, it is said to be “non-activated”. Electrical stimulation must always occur between two or more electrodes (so that the electrical current associated with the stimulus has a path from the IPG to the tissue to be stimulated, and a return path from the tissue to the IPG). The case of the IPG may function, in some modes of operation, as a return electrode ER. Monopolar stimulation occurs when a selected one of the electrodes of one of the leads 20 or 30 is activated along with the return electrode ER.
- Bipolar stimulation occurs when two of the electrodes of the leads 20 or 30 are activated, e.g., when electrode E 3 of lead 20 is activated as an anode at the same time that electrode E 11 of lead 30 is activated as a cathode.
- Tripolar stimulation occurs when three of the electrodes of the leads 20 or 30 are activated, e.g., when electrodes E 4 and E 5 of lead 20 are activated as an anode at the same time that electrode E 13 of lead 30 is activated as a cathode.
- multipolar stimulation occurs when multiple electrodes of the leads 20 or 30 are activated.
- the IPG 40 is typically programmed, or controlled, through the use of an external (non-implanted) programmer 60 .
- the external programmer 60 is coupled to the IPG 40 through a suitable communications link, represented in FIG. 1 by the wavy arrow 50 .
- Such link 50 passes through the skin 18 of the patient.
- Representative links that may be used to couple the programmer 60 with the IPG 40 include a radio frequency (RF) link, an inductive link, an optical link, or a magnetic link.
- RF radio frequency
- the programmer 60 or other similar external device, may also be used to couple power into the IPG for the purpose of operating the IPG or charging a replenishable power source, e.g., a rechargeable battery, within the IPG.
- a replenishable power source e.g., a rechargeable battery
- FIG. 2 there is shown a representative functional block diagram of one type of IPG 40 that may be used with a neurostimulation system.
- the IPG 40 therein depicted is made up of a multiplicity of dual current sources 42 .
- Each dual current source 42 includes a positive current source, i.e., a current source that can function as an anode to “source” current to a load, and a current source that can function as a cathode to “sink” current from a load through the same node.
- the “load” is the tissue that resides between the two or more activated electrodes, and includes the wire (or other conductive element) and a coupling capacitor C that connects the electrode to the common node of the dual current source.
- a first dual current source connected to electrode E 1 of a first lead through a coupling capacitor C may be programmed to produce a current of +I 1 or ⁇ I 1 through electrode E 1 , depending upon whether such dual current source is configured to operate as a cathode or an anode, when such first dual current source is turned on or enabled.
- a second current source, connected to electrode E 2 when turned on or enabled, may be programmed to produce a current of +I 2 or ⁇ I 2 through electrode E 2 .
- a third current source when enabled, may be programmed to produce a current of +I 3 or ⁇ I 3 through electrode E 3 .
- An nth current source, where n represents the number of electrodes on the first lead is similarly connected to electrode En, and may be programmed to produce a current of +In or ⁇ In through electrode En when turned on or enabled.
- each electrode is similarly connected to a dual current source.
- electrode E(n+1) is connected to a dual current source that produces a current of +I(n+1) or ⁇ I(n+1) through electrode E(n+1) when such (n+1)th current source is enabled.
- all of the electrodes of the second lead are connected to respective dual current sources.
- 2n dual current sources that are respectively connected to each of the 2n electrodes of the first and second leads (n electrodes on each lead).
- Alternative embodiments may employ less than 2n dual current sources connected to 2n electrodes through a suitable multiplexer circuit.
- a programmable current control circuit 44 is also provided within the IPG 40 that controls, i.e., turns on or enables, at specified times, a selected current source to operate as either a cathode or an anode to source or sink a current having a desired amplitude.
- the control circuit 44 also disables, or turns off, selected current sources, as controlled by programmed control data received from the external programmer, or otherwise resident within the IPG.
- the control circuit 44 further includes the ability to measure the electrode voltage, E V1 , E V2 , E V3 , . . . E Vn , . . . E V(2n) , appearing at the output of each dual current source 42 , whether the electrode is activated or non-activated. This effectively allows the electrode voltage, or electric field at the electrode, to be measured, which in turn facilitates impedance or field potential measurements to be made, which measurements are used in carrying out various steps of the invention as described below.
- current control circuit 44 may turn on current sources +I 1 and +I 2 at the same time, i.e., during a time period T 1 , that current source ⁇ I(n+2) is turned on. All other current sources are turned off, or disabled, during the time T 1 .
- Such action causes electrodes E 1 and E 2 to be activated as anodes at the same time that electrode E(n+2) is activated as a cathode. That is, a current +I 1 is “sourced” from electrode E 1 and a current +I 2 is “sourced” from electrode E 2 at the same time that a current ⁇ I(n+2) is “sunk” into electrode E(n+2).
- the amplitudes of the currents +I 1 and +I 2 may be any programmed values, and the amplitude of the current ⁇ I(n+2) should be equal to ⁇ (I 1 +I 2 ). That is, the current that is sourced is equal to the current that is sunk.
- a biphasic stimulation pulse 46 is produced that is characterized by a first pulse (during time period T 1 ) of one polarity, followed by a second pulse immediately or shortly thereafter (during time period T 2 ) of the opposite polarity.
- the electrical charge associated with the first pulse is made so that it is equal to the charge associated with the second pulse, thereby maintaining charge balance during the stimulation. (Maintaining charge balance when stimulating living tissue is generally considered an important component of a stimulation regime.) Charge balance is commonly achieved in a biphasic pulse 46 by making the amplitude of the first pulse during time T 1 equal to the amplitude of the second pulse during time period T 2 , where T 1 equals T 2 . However, charge balance may also be achieved using other combinations of pulse duration and amplitude, e.g., by making the amplitude of the second pulse equal to 1 ⁇ 2 the amplitude of the first pulse, while making the time period T 2 equal to twice the time period T 1 .
- FIG. 3 a functional block diagram of another type of IPG 40 ′ that may be used in a neurostimulation system is shown.
- the IPG 40 ′ shown in FIG. 3 includes a multiplicity of dual voltage sources 42 ′, each being connected to one of the electrodes E 1 , E 2 , E 3 , . . . En, of a first lead, or to one of the electrodes E(n+1), E(n+2), . . . E(2n), of a second lead.
- Each dual voltage source 42 ′ applies a programmed voltage, of one polarity or another, to its respective electrode, when enabled or turned on. For the configuration shown in FIG.
- a separate dual voltage source 42 ′ is connected to each electrode node through a coupling capacitor C.
- a coupling capacitor C may be used to connect to each electrode node through a multiplexer circuit.
- the control circuit 44 ′ further includes the ability to measure the electrode current, E I1 , E I2 , E I3 , . . . E In , . . . E I(2n) , flowing to or from its respective electrode, whether the electrode is activated or non-activated, and the electrode voltage, E V1 , E V2 , E V3 , . . . E Vn , . . . E V(2n) , appearing at the output of each non-activated dual voltage source 42 ′
- These measurements facilitate impedance and electric field measurements or calculations to be made, which measurements are used in carrying out various steps of the invention as described below.
- a programmable voltage control circuit 44 ′ controls each of the dual voltage sources 42 ′, specifying the amplitude, polarity, and duration of the voltage that is applied to its respective terminal.
- stimulation is achieved by applying a biphasic stimulation pulse 46 ′ to the selected electrodes, wherein a voltage of a first polarity and amplitude is applied during time period T 3 , followed by a voltage of the appositive polarity and amplitude during time period T 4 .
- the biphasic stimulation pulse 46 ′ may be applied between any two or more electrodes.
- FIGS. 2 and 3 are functional diagrams only, and are not intended to be limiting. Those of skill in the art, given the descriptions presented herein, should be able to readily fashion numerous types of IPG circuits, or equivalent circuits, that carry out the functions indicated and described, which functions include not only producing a stimulus current or voltage on selected groups of electrodes, but also the ability to measure the voltage, or the current, flowing through an activated or non-activated electrode. Such measurements allow impedance to be determined (used with a first embodiment of the invention) or allow electric field potentials to be measured (used with a second embodiment of the invention), as described in more detail below.
- a preferred IPG is described in international patent application WO 02/09808 A1 (published 7 Feb. 2002); and in U.S. patent application Ser. No. 09/626,010, filed Jul. 26, 2000, which publication and application have been previously referenced and are incorporated herein by reference.
- the present invention addresses the problem of determining the relative position between electrodes once the leads on which the electrodes are carried have been implanted.
- the present invention uses: (1) interelectrode impedance (one technique or embodiment) or (2) measured field potentials (another technique or embodiment) to determine the relative orientation of one electrode on an implanted lead to other electrodes on the implanted lead or adjacent implanted leads in the spinal column or other body/tissue location.
- the interelectrode impedance technique of the invention is performed by measuring impedance vectors.
- a vector is defined as an impedance value measured between two electrodes in the body.
- the value of the impedance vector is due primarily to two physical entities:
- the impedance tomography technique of the present invention relies upon the latter of the above two physical entities, i.e., upon the bulk impedance between the electrodes.
- the bulk impedance portion of the impedance vector may be further broken up into two contributing factors: (a) the impedance of the tissue adjacent to the electrodes; and (b) the impedance of the tissue between the electrodes.
- the first factor (part a) makes up the majority of the measurement, due to the higher and non-uniform current densities near the electrode surface.
- the second factor (part b) where the current density is more uniform, has a roughly linear relationship to distance between the two electrodes, due to the definition of resistance. Resistance, R, is defined as
- R (resistivity) ⁇ (distance)/cross-sectional area.
- the second factor (part b) is used by the interelectrode impedance technique embodiment of the invention to determine the relative spacing between electrodes and to determine the relative orientation of the leads.
- one first-order, simple embodiment of the invention is as follows:
- each having four electrodes each having four electrodes (the electrodes of one lead being designated as e 1 , e 2 , e 3 , and e 4 ; and the electrodes of the other lead being designated as E 5 , E 6 , E 7 and E 8 ), their relative orientation may be inferred by making the following measurements:
- the monopolar impedances are used to “correct” the bipolar impedances for the first factor of bulk impedance, the strongly-weighted impedance near the electrode.
- the corrected bipolar impedances are then used to develop an impedance “map” between the electrodes. This map reveals the relative orientation of the leads.
- offset an estimate of the impedance in the monopolar impedance measurement that is NOT due to the tissue near the electrode.
- the relative orientation of the leads may be inferred by the relative minima of the impedance values. Where the corrected bipolar impedance between two electrodes is a minimum relative to other electrodes on an opposing array, those electrodes are relatively adjacent.
- This information may then be loaded into a programmer, which can then provide a graphic display of the assumed relative lead positions. Such data and/or display might then be compared with previously measured or entered and stored graphics, indicating earlier orientations. Such comparison can thus help the physician/clinician to track the lead orientation to determine appropriate programming, reprogramming, or need for surgical revision.
- the present invention may be used to automatically setup the appropriate navigation tables for steering multiple lead systems.
- FIG. 4 illustrates data showing this simple embodiment applied to data from a patient with dual quadrapolar leads, which leads are oriented as depicted in FIG. 5 .
- FIG. 6 shows the impedance map resulting from the measurements of FIG. 4 . It can be seen that the impedance maps ( FIG. 6 ) correlate well to the orientation of the leads ( FIG. 5 ).
- the simple interelectrode impedance technique described above may be enhanced by making more accurate corrections using the appropriate field equations to calculate the monopolar and bipolar impedance of the electrodes. Also, other geometric methods may be employed using the improved “distance impedance” values to improve the mapping of the electrode orientations.
- Such alternative technique utilizes electric field measurements of the implanted electrodes, and more particularly, electric field measurements on non-active electrodes caused by activation of other electrodes.
- a constant current is sourced (anodes) and sunk (cathodes) from a predefined combination of electrodes.
- Such electrodes thus comprise the activated electrodes.
- the resulting potentials are measured at all other electrodes (those not involved in sourcing or sinking current), i.e., the non-activated electrodes. From these measured potentials, the relative orientation of the electrodes, and the leads on which the electrodes are carried, may be determined.
- the use of field potentials represents an improvement over the use of impedance measurements, since the measured potential values are less subject to the confounding effects of the tissue impedance very close to the source/sink electrodes.
- FIG. 7 represents the relative position of dual quadrapolar leads 21 and 31 after being implanted in a patient, as obtained using a fluoroscopic imaging device.
- the necessary imaging equipment needed to obtain a fluoroscopic image such as is shown in FIG. 7 , is not readily available.
- the present electrical field potential measurement technique represents an alternative approach to obtaining relative electrode position information rather than using an expensive and cumbersome imaging device.
- the first technique is monopolar (current delivered or sourced from one electrode—the cathode—and sunk to the return electrode ER—the anode). Thus, for each active monopolar combination, there are seven non-active electrodes on which the electric field may be measured.
- the second technique is flanked tripolar stimulation (current delivered between two anodes and one cathode, with the cathode being flanked on each side by an anode).
- a constant current is delivered to each electrode implanted in the patient's body while the electric field potential is measured on all other electrodes NOT involved in sinking/sourcing current.
- the constant current may be set to a subperception level, or to another suitable level that is comfortable for the patient.
- the electric field potentials for the monopolar stimulation are plotted on the same chart in FIG. 8 .
- the vertical axis is millivolts.
- the electrodes closest to the source electrode have a high potential (note: all plots in FIG. 8 and FIG. 9 are “negative”, i.e., more negative potentials results in more positive measured values, as shown in the plots).
- electrode E 8 curve 71
- electrode E 8 is closest to electrode E 4 , somewhat further from electrode E 3 , and farthest from electrodes E 2 and E 1 .
- a similar analysis for the monopolar stimulation fields of the other electrodes reveals a similar relationship: the electrodes closest to the source electrode have the higher potential.
- the electric field potentials for the tripolar stimulation are plotted on the same chart in FIG. 9 .
- the vertical axis is millivolts.
- a better relative orientation can be obtained than can be obtained with the monopolar stimulation.
- Those electrodes closest to the cathode have a high potential while those electrodes closest to the anode have a lower potential relative to the electrodes further away.
- curve 72 shows the electric field potential of the non-active electrodes relative to the tripolar stimulation of electrodes E 2 E 3 E 4 , with E 2 and E 4 being anodes, and E 3 being a cathode.
- E 2 and E 4 being anodes
- E 3 being a cathode.
- curve 72 has a peak corresponding to electrode E 7 , which means electrode E 7 is closest to the cathode E 3 .
- Curve 72 further has lows or valleys corresponding to electrodes E 6 and E 8 , which means E 6 and E 8 are closest to anode electrodes E 2 and E 4 .
- the actual orientation of the electrodes shown in FIG. 7 reveals that E 6 is closest to E 2 , and E 8 is closest to E 4 .
- those electrodes closest to the flanked cathodic electrode have a high potential while those electrodes closest to the anodic electrodes, on either side of the cathodic electrode, have a lower potential relative to the electrodes further away.
- the relative orientation of the neurostimulation leads may be determined. Once known, the relative orientation may be used to track lead migration, to setup stimulation configurations and parameters for nominal stimulation and/or navigation, and to automatically adjust stimulation energy to a previously-defined optimal potential field in the case of lead migration or postural changes.
- a first step involves applying suitable stimuli, e.g., subperception stimuli, to a selected group of electrodes (block 82 ). Such application of stimuli defines the activated electrodes. While the stimuli are being applied to the activated electrodes, the electric field at the non-activated electrodes is measured (block 84 ) and saved (block 86 ) as electric field data (Block 86 ).
- suitable stimuli e.g., subperception stimuli
- the previously-saved electric field data may have been obtained during initial implantation of the leads, or during the last visit (several weeks or months ago) to the doctor. Or, the previously-saved electric field data may have been obtained just a new hours or minutes ago at a time when the patient's body had assumed a different posture position.
- the purpose of the comparison performed at block 88 of FIG. 10 is to determine if the relative position of the leads has changed, which change in position would also have caused a relative change in the position of the electrodes carried on the leads. Such determination may be made by analyzing the electric field data (block 90 ) as described above in connection with FIG. 8 and/or FIG. 9 to determine whether the relative electrode orientation has changed.
- the magnitude of the difference in the compared electric field data may advantageously provide a relative measure of how far the lead has shifted or moved since the last electric field data was obtained.
- appropriate correction action may be taken, as needed (block 92 ).
- the corrective action taken at block 92 of FIG. 10 may include, for example, simply tracking the lead migration over time, so that other corrective action, e.g., surgery to reposition the leads, can be taken when necessary. Even if new surgery to reposition the leads is not needed, simply mapping the lead migration overtime will enable reprogramming of the stimuli parameters as needed so that a desired effect can be obtained regardless of the lead movement.
- the corrective action may further include setting up stimulation configurations and parameters for providing nominal stimulation suitable for the electrodes in their new relative positions. For example, the amplitude of the stimulus applied to one electrode may be decreased if it is determined that the electrode has migrated closer to another stimulating electrode of the same polarity during stimulation, thereby preserving approximately the same stimulation effect for the patient. Alternatively, the amplitude of the stimulus applied to the electrode may be increased if the electrode has migrated closer to a stimulating electrode of the opposite polarity. Such amplitude adjustments may be made manually or automatically, depending on the mode of operation of the neurostimulation system.
- Yet another corrective action that may be taken at block 92 of FIG. 10 is to adjust the distribution of the stimuli to a new location through navigation.
- Navigation involves electronically shifting the stimulus current from one group of electrodes to another so as to shift or move the location where the patient feels the most beneficial paresthesia, and/or receives the most benefit.
- Such navigation allows the neurostimulation system to be quickly “fitted” to a given patient. Fitting the neurostimulation system to the patient is necessary after the system is first implanted, and may also be necessary whenever the leads (electrodes) have moved.
- the present invention thus provides a relatively easy way to determine whether such lead movement has occurred, and thereby whether a refitting is or may be necessary.
- Yet additional corrective action that may be taken at block 92 of FIG. 10 in response to a determination that lead migration or postural changes have occurred includes manually or automatically adjusting the stimulation energy to a previously-defined optimal potential field.
- the present invention uses a measure of impedance or electric field to determine relative lead positions for multipolar leads in a multi-lead configuration of a neurostimulation system, e.g., a spinal cord stimulation system.
- a neurostimulation system e.g., a spinal cord stimulation system.
- the invention uses impedance or electric field measurements to determine relative lead positions, which impedance or electric field measurements may be used as an automated or assistive method for setting up a programmer for navigation, other programming, or diagnostic evaluations in spinal cord (or other neural) stimulation.
- the invention may be directed to the storing of impedance or electric field maps to chronically track relative lead positions in a programmer linked to a database, along with other patient data.
Landscapes
- Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
Interelectrode impedance or electric field potential measurements are used to determine the relative orientation of one lead to other leads in the spinal column or other body/tissue location. Interelectrode impedance is determined by measuring impedance vectors. The value of the impedance vector is due primarily to the electrode-electrolyte interface, and the bulk impedance between the electrodes. The bulk impedance between the electrodes is, in turn, made up of (1) the impedance of the tissue adjacent to the electrodes, and (2) the impedance of the tissue between the electrodes. In one embodiment, the present invention makes both monopolar and bipolar impedance measurements, and then corrects the bipolar impedance measurements using the monopolar measurements to eliminate the effect of the impedance of the tissue adjacent the electrodes. The orientation and position of the leads may be inferred from the relative minima of the corrected bipolar impedance values. These corrected impedance values may also be mapped and stored to facilitate a comparison with subsequent corrected impedance measurement values. Such comparison allows a determination to be made as to whether the lead position and/or orientation has changed appreciably over time. In another embodiment, one or more electrodes are stimulated and the resulting electric field potential on the non-stimulated electrodes is measured. Such field potential measurements provide an indication of the relative orientation of the electrodes. Once known, the relative orientation may be used to track lead migration, to setup stimulation configurations and parameters for nominal stimulation and/or navigation. Also, such measurements allow automatic adjustment of stimulation energy to a previously-defined optimal potential field in the case of lead migration or postural changes.
Description
- The present is a continuation of U.S. application Ser. No. 10/310,202, filed Dec. 3, 2002, to be issued on Jan. 31, 2006 as U.S. Pat. No. 6,993,384, which application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/338,331, filed Dec. 4, 2001, each of which is incorporated herein by reference.
- The present invention relates to neurostimulation systems, such as a spinal cord stimulation (SCS) system, and more particularly to a method for determining the relative position and orientation of electrodes on a neurostimulation lead or leads used with such a system.
- In SCS systems, positioning of the leads is critical to the success of the therapy. During surgery, the physician places the leads in a very careful manner in order to locate the electrodes proximal to neural elements that are the target of the stimulation. During and after placement, stimulation energy is delivered to verify that the leads are indeed stimulating the appropriate neural elements.
- However, if the leads happen to shift position, the targeted neural elements may no longer be appropriately stimulated. At best, this can require electrical reprogramming to restore therapy or, at worst, surgical revision, where a second surgery is required and the leads must be manually readjusted. In the first case, the physician may have only a suspicion that a lead has shifted position, based on patient reporting of paresthesia, which is not foolproof. Also, attempting to reprogram the leads based on paresthesia locations can be challenging.
- What is needed is a more objective technique for verifying the position of the leads.
- Prior art approaches for determining the lead position are disclosed in U.S. Pat. Nos. 4,486,835; 4,539,640; and 5,184,624, which patents are incorporated herein by reference.
- The present invention addresses the above and other needs by providing a cross-check technique for verifying the position of the electrodes of the implanted leads. A first technique involves the use of interelectrode impedance. A second technique involves measured field potentials. Either technique advantageously allows the relative orientation of one electrode on an implanted lead to other electrodes on the implanted lead or adjacent implanted leads in the spinal column or other body/tissue location to be readily determined. Such techniques are useful not only for reprogramming, but also to estimate if the shifted orientation of the electrodes is sufficiently large so as to make electrical reprogramming a waste of time, thereby suggesting that surgery may need to be performed for repositioning.
- At present, the correct lead position may only be determined by X-ray or fluoroscopy. Disadvantageously, X-ray and fluoroscopy require expensive equipment, significant time, and appropriate medical facilities, most of which are not readily available.
- The general process for fitting a neurostimulation patient, i.e, a spinal cord stimulation patient, is described, e.g., in U.S. Pat. Nos. 6,052,624; 6,393,325; in published international patent application WO 02/09808 A1 (published 7 Feb. 2002); and in U.S. patent applications (assigned to the same assignee as the present application) Ser. No. 09/626,010, filed Jul. 26, 2000; and Ser. No. 09/740,339, filed Dec. 18, 2000, which patents, publication, and applications are incorporated herein by reference. As indicated in those documents, prior to fitting a patient with the certain types of neurostimulation leads, the relative orientation of the electrodes on the implanted leads should be known in order to allow appropriate navigation of the stimulation energy. At present, a determination of the relative orientation typically requires that a fluoroscope or X-ray image of the implanted leads be present at the time of patient setup with the system programmer. Disadvantageously, however, such images may not always be available. Moreover, between the time of implant and follow-up visits, the leads may have shifted and the fluoroscope image may no longer be valid. This can result in poor patient outcomes due to inappropriate or unexpected stimulation effects during fitting.
- Hence, it is seen that there is a need for the cross-check techniques provided by the present invention, which techniques can be used to verify the position of the leads at numerous times during the lifetime of the implanted leads, e.g., during initial implantation and programming, during followup visits, throughout the trial period, and during subsequent reprogramming sessions.
- The aspects, features and advantages of the present invention will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings wherein:
-
FIG. 1 illustrates a neurostimulation system wherein two leads, each having eight in-line electrodes thereon, are positioned side-by-side, and wherein each lead is connected to an implantable pulse generator (IPG), which IPG is, in turn, coupled to an external programmer; -
FIG. 2 shows a functional block diagram of an IPG that uses multiple programmable current sources to activate selected electrodes of the neurostimulation leads; -
FIG. 3 shows a functional block diagram of an IPG that uses multiple programmable voltage sources to activate selected electrodes of the neurostimulation leads; -
FIG. 4 is a table that contains impedance vector and distance impedance data in accordance with one embodiment of the invention; -
FIG. 5 illustrates representative relative electrode orientation in a patient having dual quadrapolar leads (two side-by-side leads, each having four in-line electrodes thereon); -
FIG. 6 is an impedance map that illustrates application of one embodiment of the invention to the electrode orientation shown inFIG. 5 ; -
FIG. 7 depicts a representative fluoroscopic image of dual quadrapolar leads in a patient; -
FIG. 8 illustrates, in accordance with another embodiment of the invention, the measured electrode potential of non-activated electrodes on the dual quadrapolar lead ofFIG. 7 when the activated electrode is activated through monopolar stimulation; -
FIG. 9 illustrates the measured electrode potential of non-activated electrodes on the dual quadrapolar lead ofFIG. 7 when the activated electrodes are activated through tripolar stimulation; and -
FIG. 10 is a flowchart that highlights the main steps used with one embodiment of the present invention. - Corresponding reference characters indicate corresponding components throughout the several views of the drawings.
- The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing the general principles of the invention. The scope of the invention should be determined with reference to the claim(s).
- The present invention uses: (1) interelectrode impedance (one technique or embodiment) or (2) measured field potentials (another technique or embodiment) to determine the relative orientation of one electrode on an implanted lead to other electrodes on the implanted lead or adjacent implanted leads in the spinal column or other body/tissue location.
- Before describing the two techniques, either of which may be used, it will be helpful to first briefly provide an overview of a representative neurostimulation system of the type with which the present invention may be used. A representative neurostimulation system is illustrated in
FIG. 1 . Such system may include a firstimplantable lead 20 and a secondimplantable lead 30. Each lead includes a series of in-line electrodes thereon. For the example shown inFIG. 1 , thefirst lead 20 contains eight in-line electrodes E1, E2, E3, . . . E8. Thesecond lead 30 also contains eight in-line electrodes E9, E10, E11, . . . E16. - Each of the electrodes of each
lead lead 20, for example, may be characterized as a bundle ofwires 22 that are electrically connected with the IPG 40. Similarly, the wires connected to the electrodes E9, E10, E11, . . . E16 oflead 30 may be characterized as a bundle ofwires 32 that are electrically connected with the IPG 40. Through these wires, carried within the respective leads 20 or 30, the IPG is able to direct electrical stimulation to selected electrodes of each lead. - When a given electrode is selected to receive an electrical stimulus, it is (for purposes of the present invention) said to be “activated”. When an electrode is not selected to receive an electrical stimulus, it is said to be “non-activated”. Electrical stimulation must always occur between two or more electrodes (so that the electrical current associated with the stimulus has a path from the IPG to the tissue to be stimulated, and a return path from the tissue to the IPG). The case of the IPG may function, in some modes of operation, as a return electrode ER. Monopolar stimulation occurs when a selected one of the electrodes of one of the
leads leads lead 20 is activated as an anode at the same time that electrode E11 oflead 30 is activated as a cathode. Tripolar stimulation occurs when three of the electrodes of theleads lead 20 are activated as an anode at the same time that electrode E13 oflead 30 is activated as a cathode. In general, multipolar stimulation occurs when multiple electrodes of theleads - The
IPG 40 is typically programmed, or controlled, through the use of an external (non-implanted)programmer 60. Theexternal programmer 60 is coupled to theIPG 40 through a suitable communications link, represented inFIG. 1 by thewavy arrow 50. Such link 50 passes through theskin 18 of the patient. Representative links that may be used to couple theprogrammer 60 with theIPG 40 include a radio frequency (RF) link, an inductive link, an optical link, or a magnetic link. Theprogrammer 60, or other similar external device, may also be used to couple power into the IPG for the purpose of operating the IPG or charging a replenishable power source, e.g., a rechargeable battery, within the IPG. Once theIPG 40 has been programmed, and its power source has been fully charged or replenished, it may operate as programmed without the need for theexternal programmer 60 to be present. - Turning next to
FIG. 2 , there is shown a representative functional block diagram of one type ofIPG 40 that may be used with a neurostimulation system. As seen inFIG. 2 , theIPG 40 therein depicted is made up of a multiplicity of dualcurrent sources 42. Each dualcurrent source 42 includes a positive current source, i.e., a current source that can function as an anode to “source” current to a load, and a current source that can function as a cathode to “sink” current from a load through the same node. The “load” is the tissue that resides between the two or more activated electrodes, and includes the wire (or other conductive element) and a coupling capacitor C that connects the electrode to the common node of the dual current source. - Thus, for example, and as depicted in
FIG. 2 , a first dual current source connected to electrode E1 of a first lead through a coupling capacitor C, may be programmed to produce a current of +I1 or −I1 through electrode E1, depending upon whether such dual current source is configured to operate as a cathode or an anode, when such first dual current source is turned on or enabled. Similarly, a second current source, connected to electrode E2, when turned on or enabled, may be programmed to produce a current of +I2 or −I2 through electrode E2. In a similar manner, a third current source, when enabled, may be programmed to produce a current of +I3 or −I3 through electrode E3. An nth current source, where n represents the number of electrodes on the first lead, is similarly connected to electrode En, and may be programmed to produce a current of +In or −In through electrode En when turned on or enabled. - If a second lead, also having n electrodes, is positioned adjacent the first lead, each electrode is similarly connected to a dual current source. For example, electrode E(n+1) is connected to a dual current source that produces a current of +I(n+1) or −I(n+1) through electrode E(n+1) when such (n+1)th current source is enabled. In like manner, all of the electrodes of the second lead are connected to respective dual current sources. There are thus 2n dual current sources that are respectively connected to each of the 2n electrodes of the first and second leads (n electrodes on each lead). Alternative embodiments (not shown) may employ less than 2n dual current sources connected to 2n electrodes through a suitable multiplexer circuit.
- A programmable
current control circuit 44 is also provided within theIPG 40 that controls, i.e., turns on or enables, at specified times, a selected current source to operate as either a cathode or an anode to source or sink a current having a desired amplitude. Thecontrol circuit 44 also disables, or turns off, selected current sources, as controlled by programmed control data received from the external programmer, or otherwise resident within the IPG. Thecontrol circuit 44 further includes the ability to measure the electrode voltage, EV1, EV2, EV3, . . . EVn, . . . EV(2n), appearing at the output of each dualcurrent source 42, whether the electrode is activated or non-activated. This effectively allows the electrode voltage, or electric field at the electrode, to be measured, which in turn facilitates impedance or field potential measurements to be made, which measurements are used in carrying out various steps of the invention as described below. - Thus, in operation, and as illustrated in
FIG. 2 ,current control circuit 44 may turn on current sources +I1 and +I2 at the same time, i.e., during a time period T1, that current source −I(n+2) is turned on. All other current sources are turned off, or disabled, during the time T1. Such action causes electrodes E1 and E2 to be activated as anodes at the same time that electrode E(n+2) is activated as a cathode. That is, a current +I1 is “sourced” from electrode E1 and a current +I2 is “sourced” from electrode E2 at the same time that a current −I(n+2) is “sunk” into electrode E(n+2). The amplitudes of the currents +I1 and +I2 may be any programmed values, and the amplitude of the current −I(n+2) should be equal to −(I1+I2). That is, the current that is sourced is equal to the current that is sunk. - After the time period T1, it is common to switch the polarities of the electrodes during a second time period T2. During T2, the electrodes E1 and E2 are activated as cathodes, so that they both sink current, and electrode E(n+2) is activated as an anode, so that it sourches a current equal in amplitude to the current that is sunk by electrodes E1 and E2. In this manner, a
biphasic stimulation pulse 46 is produced that is characterized by a first pulse (during time period T1) of one polarity, followed by a second pulse immediately or shortly thereafter (during time period T2) of the opposite polarity. The electrical charge associated with the first pulse is made so that it is equal to the charge associated with the second pulse, thereby maintaining charge balance during the stimulation. (Maintaining charge balance when stimulating living tissue is generally considered an important component of a stimulation regime.) Charge balance is commonly achieved in abiphasic pulse 46 by making the amplitude of the first pulse during time T1 equal to the amplitude of the second pulse during time period T2, where T1 equals T2. However, charge balance may also be achieved using other combinations of pulse duration and amplitude, e.g., by making the amplitude of the second pulse equal to ½ the amplitude of the first pulse, while making the time period T2 equal to twice the time period T1. - Next, with respect to
FIG. 3 , a functional block diagram of another type ofIPG 40′ that may be used in a neurostimulation system is shown. TheIPG 40′ shown inFIG. 3 , includes a multiplicity ofdual voltage sources 42′, each being connected to one of the electrodes E1, E2, E3, . . . En, of a first lead, or to one of the electrodes E(n+1), E(n+2), . . . E(2n), of a second lead. Eachdual voltage source 42′ applies a programmed voltage, of one polarity or another, to its respective electrode, when enabled or turned on. For the configuration shown inFIG. 3 , a separatedual voltage source 42′ is connected to each electrode node through a coupling capacitor C. (Other embodiments, not shown, may use one or two or more voltage sources that are selectively connected to each electrode node through a multiplexer circuit.) - The
control circuit 44′, or other circuitry within theIPG 40′, further includes the ability to measure the electrode current, EI1, EI2, EI3, . . . EIn, . . . EI(2n), flowing to or from its respective electrode, whether the electrode is activated or non-activated, and the electrode voltage, EV1, EV2, EV3, . . . EVn, . . . EV(2n), appearing at the output of each non-activateddual voltage source 42′ These measurements facilitate impedance and electric field measurements or calculations to be made, which measurements are used in carrying out various steps of the invention as described below. - A programmable
voltage control circuit 44′ controls each of thedual voltage sources 42′, specifying the amplitude, polarity, and duration of the voltage that is applied to its respective terminal. Typically, stimulation is achieved by applying abiphasic stimulation pulse 46′ to the selected electrodes, wherein a voltage of a first polarity and amplitude is applied during time period T3, followed by a voltage of the appositive polarity and amplitude during time period T4. Thebiphasic stimulation pulse 46′ may be applied between any two or more electrodes. - It should be noted that the functional block diagrams of
FIGS. 2 and 3 are functional diagrams only, and are not intended to be limiting. Those of skill in the art, given the descriptions presented herein, should be able to readily fashion numerous types of IPG circuits, or equivalent circuits, that carry out the functions indicated and described, which functions include not only producing a stimulus current or voltage on selected groups of electrodes, but also the ability to measure the voltage, or the current, flowing through an activated or non-activated electrode. Such measurements allow impedance to be determined (used with a first embodiment of the invention) or allow electric field potentials to be measured (used with a second embodiment of the invention), as described in more detail below. A preferred IPG is described in international patent application WO 02/09808 A1 (published 7 Feb. 2002); and in U.S. patent application Ser. No. 09/626,010, filed Jul. 26, 2000, which publication and application have been previously referenced and are incorporated herein by reference. - With the descriptions of
FIGS. 1-3 thus providing background information relative to a neurostimulation system, the present invention will next be described. As has been indicated, the present invention addresses the problem of determining the relative position between electrodes once the leads on which the electrodes are carried have been implanted. The present invention uses: (1) interelectrode impedance (one technique or embodiment) or (2) measured field potentials (another technique or embodiment) to determine the relative orientation of one electrode on an implanted lead to other electrodes on the implanted lead or adjacent implanted leads in the spinal column or other body/tissue location. - First, the interelectrode impedance technique of the invention will be explained in connection with
FIGS. 4-6 . The interelectrode impedance technique is performed by measuring impedance vectors. A vector is defined as an impedance value measured between two electrodes in the body. The value of the impedance vector is due primarily to two physical entities: - (1) the electrode-electrolyte interface; and
- (2) the bulk impedance between the electrodes.
- The impedance tomography technique of the present invention relies upon the latter of the above two physical entities, i.e., upon the bulk impedance between the electrodes.
- The bulk impedance portion of the impedance vector may be further broken up into two contributing factors: (a) the impedance of the tissue adjacent to the electrodes; and (b) the impedance of the tissue between the electrodes.
- The first factor (part a) makes up the majority of the measurement, due to the higher and non-uniform current densities near the electrode surface. However, the second factor (part b), where the current density is more uniform, has a roughly linear relationship to distance between the two electrodes, due to the definition of resistance. Resistance, R, is defined as
-
R=(resistivity)×(distance)/cross-sectional area. - The second factor (part b) is used by the interelectrode impedance technique embodiment of the invention to determine the relative spacing between electrodes and to determine the relative orientation of the leads.
- By way of example, one first-order, simple embodiment of the invention is as follows:
- If two multipolar leads are placed in the spinal column, see
FIG. 5 , each having four electrodes (the electrodes of one lead being designated as e1, e2, e3, and e4; and the electrodes of the other lead being designated as E5, E6, E7 and E8), their relative orientation may be inferred by making the following measurements: - 1. Monopolar impedances for all electrodes; and
- 2. Bipolar impedances between each electrode on opposing leads.
- The monopolar impedances are used to “correct” the bipolar impedances for the first factor of bulk impedance, the strongly-weighted impedance near the electrode. The corrected bipolar impedances are then used to develop an impedance “map” between the electrodes. This map reveals the relative orientation of the leads.
- To illustrate, a sample correction formula is as follows:
-
(distance between two electrodes e1& e2)=(measured bipolar impedance between two electrodes e1&e2)+(2*offset)−(monopolar Z for electrode e1)−(monopolar Z for electrode e2), - where offset=an estimate of the impedance in the monopolar impedance measurement that is NOT due to the tissue near the electrode.
- After the bipolar impedances are corrected by the above formula, the relative orientation of the leads may be inferred by the relative minima of the impedance values. Where the corrected bipolar impedance between two electrodes is a minimum relative to other electrodes on an opposing array, those electrodes are relatively adjacent. This information may then be loaded into a programmer, which can then provide a graphic display of the assumed relative lead positions. Such data and/or display might then be compared with previously measured or entered and stored graphics, indicating earlier orientations. Such comparison can thus help the physician/clinician to track the lead orientation to determine appropriate programming, reprogramming, or need for surgical revision.
- Also, for some programming systems, the present invention may be used to automatically setup the appropriate navigation tables for steering multiple lead systems.
-
FIG. 4 illustrates data showing this simple embodiment applied to data from a patient with dual quadrapolar leads, which leads are oriented as depicted inFIG. 5 .FIG. 6 shows the impedance map resulting from the measurements ofFIG. 4 . It can be seen that the impedance maps (FIG. 6 ) correlate well to the orientation of the leads (FIG. 5 ). - The simple interelectrode impedance technique described above may be enhanced by making more accurate corrections using the appropriate field equations to calculate the monopolar and bipolar impedance of the electrodes. Also, other geometric methods may be employed using the improved “distance impedance” values to improve the mapping of the electrode orientations.
- Next, an alternative technique or embodiment for determining relative electrode positions for multipolar leads of a neurostimulation system will be described. Such alternative technique utilizes electric field measurements of the implanted electrodes, and more particularly, electric field measurements on non-active electrodes caused by activation of other electrodes. In a preferred embodiment of this alternative embodiment, a constant current is sourced (anodes) and sunk (cathodes) from a predefined combination of electrodes. Such electrodes thus comprise the activated electrodes. Then, the resulting potentials are measured at all other electrodes (those not involved in sourcing or sinking current), i.e., the non-activated electrodes. From these measured potentials, the relative orientation of the electrodes, and the leads on which the electrodes are carried, may be determined. Advantageously, the use of field potentials represents an improvement over the use of impedance measurements, since the measured potential values are less subject to the confounding effects of the tissue impedance very close to the source/sink electrodes.
- By way of example of this electric field potential measurement technique, consider
FIGS. 7 , 8 and 9.FIG. 7 represents the relative position of dual quadrapolar leads 21 and 31 after being implanted in a patient, as obtained using a fluoroscopic imaging device. In many instances, the necessary imaging equipment needed to obtain a fluoroscopic image, such as is shown inFIG. 7 , is not readily available. Advantageously, the present electrical field potential measurement technique represents an alternative approach to obtaining relative electrode position information rather than using an expensive and cumbersome imaging device. - Two combinations of anodes/cathodes are used to deliver current to the leads of the dual quadrapolar leads 21 and 31. The first technique is monopolar (current delivered or sourced from one electrode—the cathode—and sunk to the return electrode ER—the anode). Thus, for each active monopolar combination, there are seven non-active electrodes on which the electric field may be measured. The second technique is flanked tripolar stimulation (current delivered between two anodes and one cathode, with the cathode being flanked on each side by an anode).
- In both the monopolar stimulation and the tripolar stimulation, a constant current is delivered to each electrode implanted in the patient's body while the electric field potential is measured on all other electrodes NOT involved in sinking/sourcing current. The constant current may be set to a subperception level, or to another suitable level that is comfortable for the patient.
- The electric field potentials for the monopolar stimulation are plotted on the same chart in
FIG. 8 . The vertical axis is millivolts. As seen inFIG. 8 , the electrodes closest to the source electrode have a high potential (note: all plots inFIG. 8 andFIG. 9 are “negative”, i.e., more negative potentials results in more positive measured values, as shown in the plots). Thus, for example, consider electrode E8 (curve 71), which has its highest potential relative to electrode E4, and its lowest potential relative to electrodes E1 and E2, and an intermediate potential relative to electrode E3. This corresponds to the actual electrode positions shown inFIG. 7 , where electrode E8 is closest to electrode E4, somewhat further from electrode E3, and farthest from electrodes E2 and E1. A similar analysis for the monopolar stimulation fields of the other electrodes reveals a similar relationship: the electrodes closest to the source electrode have the higher potential. - The electric field potentials for the tripolar stimulation are plotted on the same chart in
FIG. 9 . Again, the vertical axis is millivolts. As seen inFIG. 9 , a better relative orientation can be obtained than can be obtained with the monopolar stimulation. Those electrodes closest to the cathode have a high potential while those electrodes closest to the anode have a lower potential relative to the electrodes further away. For example, considercurve 72, which shows the electric field potential of the non-active electrodes relative to the tripolar stimulation of electrodes E2E3E4, with E2 and E4 being anodes, and E3 being a cathode. As seen inFIG. 9 ,curve 72 has a peak corresponding to electrode E7, which means electrode E7 is closest to the cathode E3.Curve 72 further has lows or valleys corresponding to electrodes E6 and E8, which means E6 and E8 are closest to anode electrodes E2 and E4. The actual orientation of the electrodes shown in FIG. 7 reveals that E6 is closest to E2, and E8 is closest to E4. Thus, it is seen that those electrodes closest to the flanked cathodic electrode have a high potential while those electrodes closest to the anodic electrodes, on either side of the cathodic electrode, have a lower potential relative to the electrodes further away. - Hence, it is seen that by measuring the potential field of the non-active electrodes, when active electrodes are stimulated at constant current levels, e.g., subperception levels, the relative orientation of the neurostimulation leads may be determined. Once known, the relative orientation may be used to track lead migration, to setup stimulation configurations and parameters for nominal stimulation and/or navigation, and to automatically adjust stimulation energy to a previously-defined optimal potential field in the case of lead migration or postural changes.
- Next, with reference to
FIG. 10 , a flowchart is shown that illustrates the main steps that may be used to carry out and apply the invention described above in connection withFIGS. 7-9 . As seen inFIG. 10 , a first step involves applying suitable stimuli, e.g., subperception stimuli, to a selected group of electrodes (block 82). Such application of stimuli defines the activated electrodes. While the stimuli are being applied to the activated electrodes, the electric field at the non-activated electrodes is measured (block 84) and saved (block 86) as electric field data (Block 86). Then, a determination is made as to whether there are other groups of electrodes that should be the “activated” electrodes, so that additional electric field measurements can be made of the “non-activated” electrodes (block 85). If YES (there are more electrode groups), then the steps shown atblocks - The previously-saved electric field data may have been obtained during initial implantation of the leads, or during the last visit (several weeks or months ago) to the doctor. Or, the previously-saved electric field data may have been obtained just a new hours or minutes ago at a time when the patient's body had assumed a different posture position. Regardless of when the previously-saved electric field data was obtained, the purpose of the comparison performed at
block 88 ofFIG. 10 is to determine if the relative position of the leads has changed, which change in position would also have caused a relative change in the position of the electrodes carried on the leads. Such determination may be made by analyzing the electric field data (block 90) as described above in connection withFIG. 8 and/orFIG. 9 to determine whether the relative electrode orientation has changed. - The magnitude of the difference in the compared electric field data may advantageously provide a relative measure of how far the lead has shifted or moved since the last electric field data was obtained. Advantageously, once a determination has been made that the leads (electrodes) have shifted relative to each other, appropriate correction action may be taken, as needed (block 92).
- The corrective action taken at
block 92 ofFIG. 10 may include, for example, simply tracking the lead migration over time, so that other corrective action, e.g., surgery to reposition the leads, can be taken when necessary. Even if new surgery to reposition the leads is not needed, simply mapping the lead migration overtime will enable reprogramming of the stimuli parameters as needed so that a desired effect can be obtained regardless of the lead movement. - The corrective action may further include setting up stimulation configurations and parameters for providing nominal stimulation suitable for the electrodes in their new relative positions. For example, the amplitude of the stimulus applied to one electrode may be decreased if it is determined that the electrode has migrated closer to another stimulating electrode of the same polarity during stimulation, thereby preserving approximately the same stimulation effect for the patient. Alternatively, the amplitude of the stimulus applied to the electrode may be increased if the electrode has migrated closer to a stimulating electrode of the opposite polarity. Such amplitude adjustments may be made manually or automatically, depending on the mode of operation of the neurostimulation system.
- Yet another corrective action that may be taken at
block 92 ofFIG. 10 is to adjust the distribution of the stimuli to a new location through navigation. Navigation, as described in the previously referenced patent documents, involves electronically shifting the stimulus current from one group of electrodes to another so as to shift or move the location where the patient feels the most beneficial paresthesia, and/or receives the most benefit. Such navigation allows the neurostimulation system to be quickly “fitted” to a given patient. Fitting the neurostimulation system to the patient is necessary after the system is first implanted, and may also be necessary whenever the leads (electrodes) have moved. The present invention thus provides a relatively easy way to determine whether such lead movement has occurred, and thereby whether a refitting is or may be necessary. - Yet additional corrective action that may be taken at
block 92 ofFIG. 10 in response to a determination that lead migration or postural changes have occurred includes manually or automatically adjusting the stimulation energy to a previously-defined optimal potential field. - It is thus seen that the present invention uses a measure of impedance or electric field to determine relative lead positions for multipolar leads in a multi-lead configuration of a neurostimulation system, e.g., a spinal cord stimulation system.
- It is also seen that the invention uses impedance or electric field measurements to determine relative lead positions, which impedance or electric field measurements may be used as an automated or assistive method for setting up a programmer for navigation, other programming, or diagnostic evaluations in spinal cord (or other neural) stimulation.
- It is additionally seen that the invention may be directed to the storing of impedance or electric field maps to chronically track relative lead positions in a programmer linked to a database, along with other patient data.
- While the invention herein disclosed has been described by means of specific embodiments and applications thereof, numerous modifications and variations could be made thereto by those skilled in the art without departing from the scope of the invention set forth in the claims.
Claims (20)
1-17. (canceled)
18. A method of correcting the relative migration between neurostimulation leads implanted within a patient, the neurostimulation leads carrying an array of electrodes programmed with stimulation parameters, the method comprising:
conveying electrical current through a first group of electrodes in accordance with the stimulation parameters, thereby generating a nominal electrical field to stimulate tissue of the patient;
allowing the neurostimulation leads to migrate relative to each other, thereby changing a relative position or orientation between the neurostimulation leads;
conveying electrical energy to or from an electrode on one of the neurostimulation leads after the neurostimulation leads have migrated relative to each other;
measuring an electrical parameter at an electrode on another of the neurostimulation leads in response to the conveyance of the electrical energy;
analyzing the measured electrical parameter to determine the relative position or orientation between the migrated neurostimulation leads; and
reprogramming the electrodes with new stimulation parameters in response to the determination of the relative position or orientation between the neurostimulation leads.
19. The method of claim 18 , further comprising automatically computing the new stimulation parameters in response to determining the relative position or orientation between the neurostimulation leads.
20. The method of claim 18 , further comprising manually selecting the new stimulation parameters in response to determining the relative position or orientation between the neurostimulation leads.
21. The method of claim 18 , wherein the electrical parameter is an impedance.
22. The method of claim 18 , wherein the electrical parameter is a field potential.
23. The method of claim 18 , wherein the electrodes are reprogrammed with the new stimulation parameters to maintain the generated nominal electrical field.
24. The method of claim 18 , further comprising conveying electrical current through a second group of electrodes in accordance with the new stimulation parameters, wherein at least one of electrode in the second electrode group is not included in the first electrode group.
25. The method of claim 18 , wherein a first electrode in the first electrode group is carried by one of the neurostimulation leads, a second electrode in the first electrode group of the same polarity as the first electrode is carried by the other neurostimulation lead, the migration of the neurostimulation leads relative to each other causes the first electrode to be physically displaced closer to the second electrode, and the electrodes are reprogrammed with the new stimulation parameters to decrease the amplitude of electrical current flowing through the first electrode.
26. The method of claim 18 , wherein a first electrode in the first electrode group is carried by one of the neurostimulation leads, a second electrode in the first electrode group of the same polarity as the first electrode is carried by the other neurostimulation lead, the migration of the neurostimulation leads relative to each other causes the first electrode to be physically displaced further from the second electrode, and the electrodes are reprogrammed with the new stimulation parameters to increase the amplitude of electrical current flowing through the first electrode.
27. The method of claim 18 , further comprising:
conveying electrical energy to or from the electrode on the one neurostimulation lead before the neurostimulation leads have migrated relative to each other;
measuring another electrical parameter at the electrode on the other neurostimulation lead in response to the conveyance of the electrical energy;
storing the other electrical parameter in memory; and
comparing the electrical parameter to the other electrical parameter to determine the relative position or orientation between the neurostimulation leads.
28. The method of claim 18 , further comprising displaying the determined relative position or orientation of the neurostimulation leads.
29. A tissue stimulation system, comprising:
implantable neurostimulation leads carrying an array of electrodes;
an implantable control device programmed with stimulation parameters to convey electrical current through a first group of electrodes, thereby generating a nominal electrical field to stimulate tissue of the patient, the implantable device configured for conveying electrical energy to or from an electrode on one of the neurostimulation lead, and measuring an electrical parameter at an electrode on another of the neurostimulation leads in response to the conveyance of the electrical energy; and
an external programmer configured for analyzing the measured electrical parameter to determine the relative position or orientation between the neurostimulation leads, and for reprogramming the implantable control device with new stimulation parameters in response to determining that the neurostimulation lead have migrated relative to each other.
30. The system of claim 29 , wherein the external programmer is further configured for automatically computing the new stimulation parameters in response to determining the relative position or orientation between the neurostimulation leads.
31. The system of claim 29 , wherein the external programmer is further configured for allowing a user to manually select the new stimulation parameters in response to determining the relative position or orientation between the neurostimulation leads.
32. The system of claim 29 , wherein the electrical parameter is an impedance.
33. The system of claim 29 , wherein the electrical parameter is a field potential.
34. The system of claim 29 , wherein the external programmer is configured for reprogramming the implantable control device with the new stimulation parameters to maintain the generated nominal electrical field if the neurostimulation leads have migrated relative to each other.
35. The system of claim 29 , wherein the external programmer is configured for reprogramming the implantable control device to convey electrical current through a second group of electrodes, wherein at least one of electrode in the second electrode group is not included in the first electrode group.
36. The system of claim 29 , wherein the external programmer is further configured for displaying the determined relative position or orientation of the migrated neurostimulation leads.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/476,951 US20090248118A1 (en) | 2001-12-04 | 2009-06-02 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33833101P | 2001-12-04 | 2001-12-04 | |
US10/310,202 US6993384B2 (en) | 2001-12-04 | 2002-12-03 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US11/343,007 US8682447B2 (en) | 2001-12-04 | 2006-01-30 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US12/476,951 US20090248118A1 (en) | 2001-12-04 | 2009-06-02 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/343,007 Continuation US8682447B2 (en) | 2001-12-04 | 2006-01-30 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090248118A1 true US20090248118A1 (en) | 2009-10-01 |
Family
ID=26977277
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/310,202 Expired - Lifetime US6993384B2 (en) | 2001-12-04 | 2002-12-03 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US11/343,007 Active 2028-04-21 US8682447B2 (en) | 2001-12-04 | 2006-01-30 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US11/342,989 Active 2025-03-09 US7684869B2 (en) | 2001-12-04 | 2006-01-30 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US12/476,951 Abandoned US20090248118A1 (en) | 2001-12-04 | 2009-06-02 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/310,202 Expired - Lifetime US6993384B2 (en) | 2001-12-04 | 2002-12-03 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US11/343,007 Active 2028-04-21 US8682447B2 (en) | 2001-12-04 | 2006-01-30 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US11/342,989 Active 2025-03-09 US7684869B2 (en) | 2001-12-04 | 2006-01-30 | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
Country Status (1)
Country | Link |
---|---|
US (4) | US6993384B2 (en) |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070123765A1 (en) * | 2005-10-07 | 2007-05-31 | Hetke Jamille F | Modular multichannel microelectrode array and methods of making same |
US20090118806A1 (en) * | 2007-10-17 | 2009-05-07 | Vetter Rio J | Three-dimensional system of electrode leads |
US20090187196A1 (en) * | 2007-10-17 | 2009-07-23 | Vetter Rio J | Guide tube for an implantable device system |
US20090240314A1 (en) * | 2008-03-24 | 2009-09-24 | Kong K C | Implantable electrode lead system with a three dimensional arrangement and method of making the same |
US20090253977A1 (en) * | 2003-10-21 | 2009-10-08 | Kipke Daryl R | Intracranial neural interface system |
US20090299167A1 (en) * | 2006-01-26 | 2009-12-03 | Seymour John P | Microelectrode with laterally extending platform for reduction of tissue encapsulation |
US20100305631A1 (en) * | 2001-12-04 | 2010-12-02 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US20110093052A1 (en) * | 2009-10-16 | 2011-04-21 | Anderson David J | Neural interface system |
US20110112591A1 (en) * | 2009-11-05 | 2011-05-12 | Seymour John P | Waveguide neural interface device |
WO2012044699A2 (en) * | 2010-09-30 | 2012-04-05 | Nevro Corporation | Systems and methods for detecting intrathecal penetration |
US8498720B2 (en) | 2008-02-29 | 2013-07-30 | Neuronexus Technologies, Inc. | Implantable electrode and method of making the same |
US8676331B2 (en) | 2012-04-02 | 2014-03-18 | Nevro Corporation | Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection |
RU2509531C1 (en) * | 2012-07-04 | 2014-03-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Тамбовский государственный технический университет" ФГБОУ ВПО ТГТУ | Method for determining bioobject impedance components |
US8731673B2 (en) | 2007-02-26 | 2014-05-20 | Sapiens Steering Brain Stimulation B.V. | Neural interface system |
US8958862B2 (en) | 2007-10-17 | 2015-02-17 | Neuronexus Technologies, Inc. | Implantable device including a resorbable carrier |
US8965482B2 (en) | 2010-09-30 | 2015-02-24 | Nevro Corporation | Systems and methods for positioning implanted devices in a patient |
US9014796B2 (en) | 2005-06-14 | 2015-04-21 | Regents Of The University Of Michigan | Flexible polymer microelectrode with fluid delivery capability and methods for making same |
US9155861B2 (en) | 2010-09-20 | 2015-10-13 | Neuronexus Technologies, Inc. | Neural drug delivery system with fluidic threads |
US9289142B2 (en) | 2008-03-24 | 2016-03-22 | Neuronexus Technologies, Inc. | Implantable electrode lead system with a three dimensional arrangement and method of making the same |
US9403020B2 (en) | 2008-11-04 | 2016-08-02 | Nevro Corporation | Modeling positions of implanted devices in a patient |
US9409020B2 (en) | 2014-05-20 | 2016-08-09 | Nevro Corporation | Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods |
US9517344B1 (en) | 2015-03-13 | 2016-12-13 | Nevro Corporation | Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator |
US9884198B2 (en) | 2014-10-22 | 2018-02-06 | Nevro Corp. | Systems and methods for extending the life of an implanted pulse generator battery |
RU2669484C1 (en) * | 2017-06-27 | 2018-10-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Тамбовский государственный технический университет" (ФГБОУ ВО "ТГТУ") | Method of determining components of impedance of bio-object |
US10420935B2 (en) | 2015-12-31 | 2019-09-24 | Nevro Corp. | Controller for nerve stimulation circuit and associated systems and methods |
US10933238B2 (en) | 2019-01-31 | 2021-03-02 | Nevro Corp. | Power control circuit for sterilized devices, and associated systems and methods |
US10980999B2 (en) | 2017-03-09 | 2021-04-20 | Nevro Corp. | Paddle leads and delivery tools, and associated systems and methods |
US11420045B2 (en) | 2018-03-29 | 2022-08-23 | Nevro Corp. | Leads having sidewall openings, and associated systems and methods |
US11633604B2 (en) | 2018-01-30 | 2023-04-25 | Nevro Corp. | Efficient use of an implantable pulse generator battery, and associated systems and methods |
Families Citing this family (351)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7555346B1 (en) | 1999-01-07 | 2009-06-30 | Boston Scientific Neuromodulation Corporation | Implantable pulse generator having current steering means |
US6993384B2 (en) * | 2001-12-04 | 2006-01-31 | Advanced Bionics Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US8233991B2 (en) | 2002-02-04 | 2012-07-31 | Boston Scientific Neuromodulation Corporation | Method for programming implantable device |
US7239920B1 (en) | 2002-02-12 | 2007-07-03 | Advanced Bionics Corporation | Neural stimulation system providing auto adjustment of stimulus output as a function of sensed pressure changes |
US7317948B1 (en) | 2002-02-12 | 2008-01-08 | Boston Scientific Scimed, Inc. | Neural stimulation system providing auto adjustment of stimulus output as a function of sensed impedance |
US20030153959A1 (en) * | 2002-02-12 | 2003-08-14 | Thacker James R. | Neural stimulation system providing auto adjustment of stimulus output as a function of sensed coupling efficiency |
CA2508800A1 (en) * | 2002-12-11 | 2004-06-24 | Proteus Biomedical, Inc. | Method and system for monitoring and treating hemodynamic parameters |
JP4465349B2 (en) * | 2003-01-24 | 2010-05-19 | プロテウス バイオメディカル インコーポレイテッド | Method and system for measuring cardiac parameters |
US20070083240A1 (en) * | 2003-05-08 | 2007-04-12 | Peterson David K L | Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator |
US7582062B2 (en) * | 2003-09-12 | 2009-09-01 | Medical Research Council | Methods of neural centre location and electrode placement in the central nervous system |
US7783353B2 (en) | 2003-12-24 | 2010-08-24 | Cardiac Pacemakers, Inc. | Automatic neural stimulation modulation based on activity and circadian rhythm |
US7346382B2 (en) | 2004-07-07 | 2008-03-18 | The Cleveland Clinic Foundation | Brain stimulation models, systems, devices, and methods |
US7214189B2 (en) * | 2004-09-02 | 2007-05-08 | Proteus Biomedical, Inc. | Methods and apparatus for tissue activation and monitoring |
US7959577B2 (en) | 2007-09-06 | 2011-06-14 | Baxano, Inc. | Method, system, and apparatus for neural localization |
US7887538B2 (en) | 2005-10-15 | 2011-02-15 | Baxano, Inc. | Methods and apparatus for tissue modification |
US20110004207A1 (en) | 2004-10-15 | 2011-01-06 | Baxano, Inc. | Flexible Neural Localization Devices and Methods |
US8221397B2 (en) | 2004-10-15 | 2012-07-17 | Baxano, Inc. | Devices and methods for tissue modification |
WO2006044727A2 (en) | 2004-10-15 | 2006-04-27 | Baxano, Inc. | Devices and methods for tissue removal |
US8062300B2 (en) | 2006-05-04 | 2011-11-22 | Baxano, Inc. | Tissue removal with at least partially flexible devices |
US7738969B2 (en) | 2004-10-15 | 2010-06-15 | Baxano, Inc. | Devices and methods for selective surgical removal of tissue |
US8613745B2 (en) | 2004-10-15 | 2013-12-24 | Baxano Surgical, Inc. | Methods, systems and devices for carpal tunnel release |
US8257356B2 (en) | 2004-10-15 | 2012-09-04 | Baxano, Inc. | Guidewire exchange systems to treat spinal stenosis |
US9101386B2 (en) | 2004-10-15 | 2015-08-11 | Amendia, Inc. | Devices and methods for treating tissue |
US20060095028A1 (en) | 2004-10-15 | 2006-05-04 | Baxano, Inc. | Devices and methods for tissue access |
US7578819B2 (en) | 2005-05-16 | 2009-08-25 | Baxano, Inc. | Spinal access and neural localization |
US20110190772A1 (en) | 2004-10-15 | 2011-08-04 | Vahid Saadat | Powered tissue modification devices and methods |
US9247952B2 (en) | 2004-10-15 | 2016-02-02 | Amendia, Inc. | Devices and methods for tissue access |
US20080312660A1 (en) * | 2007-06-15 | 2008-12-18 | Baxano, Inc. | Devices and methods for measuring the space around a nerve root |
US8430881B2 (en) | 2004-10-15 | 2013-04-30 | Baxano, Inc. | Mechanical tissue modification devices and methods |
US7938830B2 (en) | 2004-10-15 | 2011-05-10 | Baxano, Inc. | Powered tissue modification devices and methods |
US8048080B2 (en) | 2004-10-15 | 2011-11-01 | Baxano, Inc. | Flexible tissue rasp |
US20100331883A1 (en) | 2004-10-15 | 2010-12-30 | Schmitz Gregory P | Access and tissue modification systems and methods |
US20090011410A1 (en) * | 2004-10-20 | 2009-01-08 | Masato Mitsuhashi | Method for tailoring administration of drugs by quantitation of mrna |
US9050455B2 (en) | 2004-10-21 | 2015-06-09 | Medtronic, Inc. | Transverse tripole neurostimulation methods, kits and systems |
US10537741B2 (en) * | 2004-12-03 | 2020-01-21 | Boston Scientific Neuromodulation Corporation | System and method for choosing electrodes in an implanted stimulator device |
EP1871470A4 (en) * | 2005-03-31 | 2011-06-01 | Proteus Biomedical Inc | Automated optimization of multi-electrode pacing for cardiac resynchronization |
US8131357B2 (en) * | 2005-04-01 | 2012-03-06 | Boston Scientific Neuromodulation Corporation | Apparatus and methods for detecting migration of neurostimulation leads |
US7406351B2 (en) | 2005-04-28 | 2008-07-29 | Medtronic, Inc. | Activity sensing for stimulator control |
WO2006119046A1 (en) * | 2005-04-30 | 2006-11-09 | Medtronic, Inc. | Impedance-based stimulation adjustment |
US7395119B2 (en) * | 2005-05-19 | 2008-07-01 | Cvrx, Inc. | Implantable electrode assembly having reverse electrode configuration |
FR2887425A1 (en) * | 2005-06-22 | 2006-12-29 | Annick Nicole Lydie Tournefier | ELECTROPHYSIOLOGICAL ANALYSIS SYSTEM |
US20090299447A1 (en) * | 2005-07-01 | 2009-12-03 | Marc Jensen | Deployable epicardial electrode and sensor array |
WO2007021804A2 (en) * | 2005-08-12 | 2007-02-22 | Proteus Biomedical, Inc. | Evaluation of depolarization wave conduction velocity |
DE102005039455B4 (en) * | 2005-08-18 | 2007-06-06 | Forschungszentrum Jülich GmbH | Implant for insertion in hollow body, cochlear implant, assembly of an implant and method of manufacture |
US8038625B2 (en) * | 2005-09-15 | 2011-10-18 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for three-dimensional mapping of electrophysiology information |
US8229545B2 (en) | 2005-09-15 | 2012-07-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for mapping complex fractionated electrogram information |
US8062298B2 (en) | 2005-10-15 | 2011-11-22 | Baxano, Inc. | Flexible tissue removal devices and methods |
US8092456B2 (en) | 2005-10-15 | 2012-01-10 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US20080086034A1 (en) | 2006-08-29 | 2008-04-10 | Baxano, Inc. | Tissue Access Guidewire System and Method |
US8366712B2 (en) | 2005-10-15 | 2013-02-05 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US7567840B2 (en) * | 2005-10-28 | 2009-07-28 | Cyberonics, Inc. | Lead condition assessment for an implantable medical device |
US8403925B2 (en) | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
US8449535B2 (en) * | 2005-12-06 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
US10362959B2 (en) * | 2005-12-06 | 2019-07-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the proximity of an electrode to tissue in a body |
US9492226B2 (en) | 2005-12-06 | 2016-11-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Graphical user interface for real-time RF lesion depth display |
WO2007070361A2 (en) | 2005-12-06 | 2007-06-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
EP1962945B1 (en) | 2005-12-06 | 2016-04-20 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US8603084B2 (en) * | 2005-12-06 | 2013-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the formation of a lesion in tissue |
US8406866B2 (en) * | 2005-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
US9254163B2 (en) | 2005-12-06 | 2016-02-09 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US20070142863A1 (en) * | 2005-12-15 | 2007-06-21 | Kerry Bradley | Apparatus and methods for stimulating tissue |
JP2009521276A (en) * | 2005-12-22 | 2009-06-04 | プロテウス バイオメディカル インコーポレイテッド | Implantable integrated circuit |
AU2007217783A1 (en) * | 2006-02-16 | 2007-08-30 | Imthera Medical, Inc. | An RFID based apparatus, system, and method for therapeutic treatment of a patient |
US8209018B2 (en) * | 2006-03-10 | 2012-06-26 | Medtronic, Inc. | Probabilistic neurological disorder treatment |
WO2007117589A2 (en) * | 2006-04-07 | 2007-10-18 | Hitachi Chemical Co., Ltd. | Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis |
CN101437549A (en) * | 2006-05-08 | 2009-05-20 | 日立化成工业株式会社 | Method for testing drug sensitivity in solid tumors by quantifying mrna expression in thinly-sliced tumor tissue |
DE202007019439U1 (en) * | 2006-10-13 | 2012-09-12 | Apnex Medical, Inc. | Devices, systems and methods for the treatment of obstructive scarfing |
US9913982B2 (en) | 2011-01-28 | 2018-03-13 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US9186511B2 (en) | 2006-10-13 | 2015-11-17 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US8855771B2 (en) | 2011-01-28 | 2014-10-07 | Cyberonics, Inc. | Screening devices and methods for obstructive sleep apnea therapy |
US9744354B2 (en) | 2008-12-31 | 2017-08-29 | Cyberonics, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US9205262B2 (en) | 2011-05-12 | 2015-12-08 | Cyberonics, Inc. | Devices and methods for sleep apnea treatment |
US7831307B1 (en) | 2006-11-07 | 2010-11-09 | Boston Scientific Neuromodulation Corporation | System and method for computationally determining migration of neurostimulation leads |
AU2006351860B2 (en) | 2006-12-15 | 2011-02-03 | Nasophlex B.V. | Resuscitation device and method for resuscitation |
US8374673B2 (en) | 2007-01-25 | 2013-02-12 | Warsaw Orthopedic, Inc. | Integrated surgical navigational and neuromonitoring system having automated surgical assistance and control |
US7987001B2 (en) | 2007-01-25 | 2011-07-26 | Warsaw Orthopedic, Inc. | Surgical navigational and neuromonitoring instrument |
CA3000408C (en) * | 2007-01-29 | 2024-04-02 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
AU2008210293B2 (en) * | 2007-02-01 | 2011-05-19 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for measuring patient activity |
US8180445B1 (en) | 2007-03-30 | 2012-05-15 | Boston Scientific Neuromodulation Corporation | Use of interphase to incrementally adjust the volume of activated tissue |
EP2152357A1 (en) * | 2007-04-30 | 2010-02-17 | Medtronic, Inc. | Shifting of electrical stimulation electrode combinations among differently sized electrode arrays |
US20090018617A1 (en) * | 2007-04-30 | 2009-01-15 | Medtronic, Inc. | Parameter-directed shifting of electrical stimulation electrode combinations |
GB0709834D0 (en) * | 2007-05-22 | 2007-07-04 | Gillbe Ivor S | Array stimulator |
US7742810B2 (en) * | 2007-05-23 | 2010-06-22 | Boston Scientific Neuromodulation Corporation | Short duration pre-pulsing to reduce stimulation-evoked side-effects |
US8612019B2 (en) | 2007-05-23 | 2013-12-17 | Boston Scientific Neuromodulation Corporation | Coupled monopolar and multipolar pulsing for conditioning and stimulation |
US11376435B2 (en) | 2007-07-20 | 2022-07-05 | Boston Scientific Neuromodulation Corporation | System and method for shaped phased current delivery |
US8036754B2 (en) | 2007-07-20 | 2011-10-11 | Boston Scientific Neuromodulation Corporation | Use of stimulation pulse shape to control neural recruitment order and clinical effect |
SE532140C2 (en) * | 2007-09-28 | 2009-11-03 | Clinical Laserthermia Systems | Device for positioning implantable leads |
EP2197535A4 (en) | 2007-10-09 | 2013-08-21 | Imthera Medical Inc | Apparatus, system, and method for selective stimulation |
US8260425B2 (en) * | 2007-10-12 | 2012-09-04 | Intelect Medical, Inc. | Deep brain stimulation system with inputs |
US20090118786A1 (en) * | 2007-11-02 | 2009-05-07 | Advanced Bionics Corporation | Automated fitting system for deep brain stimulation |
US9248280B2 (en) * | 2007-11-02 | 2016-02-02 | Boston Scientific Neuromodulation Corporation | Closed-loop feedback for steering stimulation energy within tissue |
US20090118804A1 (en) * | 2007-11-05 | 2009-05-07 | Advanced Bionics Corporation | Method of mounting minimally invasive plug electrodes within cranium of patient |
US8192436B2 (en) | 2007-12-07 | 2012-06-05 | Baxano, Inc. | Tissue modification devices |
EP2217143A4 (en) * | 2007-12-11 | 2015-04-15 | Epi Sci Llc | Electrical bioimpedance analysis as a biomarker of breast density and/or breast cancer risk |
US20090157155A1 (en) * | 2007-12-18 | 2009-06-18 | Advanced Bionics Corporation | Graphical display of environmental measurements for implantable therapies |
US8290578B2 (en) | 2007-12-28 | 2012-10-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for complex impedance compensation |
US9204927B2 (en) | 2009-05-13 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for presenting information representative of lesion formation in tissue during an ablation procedure |
US8862240B2 (en) * | 2008-01-31 | 2014-10-14 | Medtronic, Inc. | Automated programming of electrical stimulation electrodes using post-implant imaging |
US8473069B2 (en) * | 2008-02-28 | 2013-06-25 | Proteus Digital Health, Inc. | Integrated circuit implementation and fault control system, device, and method |
US20090287266A1 (en) * | 2008-05-13 | 2009-11-19 | Mark Zdeblick | High-voltage tolerant multiplex multi-electrode stimulation systems and methods for using the same |
NL2001696C2 (en) * | 2008-06-18 | 2009-12-22 | Kerphos B V | Implantable electronic system useful for producing stimulation signal to human, has controller for processing parameter values to generate control signal for stimulation device based on detected parameter values |
NL2001698C2 (en) | 2008-06-18 | 2009-12-22 | Nasophlex B V | Cardioverter / defibrillator. |
NL2001697C2 (en) | 2008-06-18 | 2009-12-22 | Nasophlex B V | Nose stimulator for producing a stimulation signal to a nose. |
NL2001694C2 (en) * | 2008-06-18 | 2009-12-22 | Nasophlex B V | Ear stimulator for producing a stimulation signal to an ear. |
US8409206B2 (en) | 2008-07-01 | 2013-04-02 | Baxano, Inc. | Tissue modification devices and methods |
US9314253B2 (en) | 2008-07-01 | 2016-04-19 | Amendia, Inc. | Tissue modification devices and methods |
US8398641B2 (en) | 2008-07-01 | 2013-03-19 | Baxano, Inc. | Tissue modification devices and methods |
WO2010006304A2 (en) | 2008-07-11 | 2010-01-14 | Boston Scientific Neuromodulation Corporation | System and method for converting tissue stimulation programs in a format usable by an electrical current steering navigator |
AU2009271047B2 (en) | 2008-07-14 | 2014-04-17 | Baxano Surgical, Inc. | Tissue modification devices |
WO2010011721A1 (en) * | 2008-07-24 | 2010-01-28 | Boston Scientific Neuromodulation Corporation | System and method for maintaining a distribution of currents in an electrode array using independent voltage sources |
WO2010011969A1 (en) | 2008-07-24 | 2010-01-28 | Boston Scientific Neuromodulation Corporation | System and method for avoiding, reversing, and managing neurological accomodation to electrical stimulation |
US7987000B2 (en) * | 2008-09-04 | 2011-07-26 | Boston Scientific Neuromodulation Corporation | Multiple tunable central cathodes on a paddle for increased medial-lateral and rostral-caudal flexibility via current steering |
US9504818B2 (en) * | 2008-09-04 | 2016-11-29 | Boston Scientific Neuromodulation Corporation | Multiple tunable central cathodes on a paddle for increased medial-lateral and rostral-caudal flexibility via current steering |
US8437857B2 (en) | 2008-09-04 | 2013-05-07 | Boston Scientific Neuromodulation Corporation | Multiple tunable central cathodes on a paddle for increased medial-lateral and rostral-caudal flexibility via current steering |
US9717910B2 (en) * | 2008-09-04 | 2017-08-01 | Boston Scientific Neuromodulation Corporation | Multiple tunable central cathodes on a paddle for increased medial-lateral and rostral-caudal flexibility via current steering |
US8442655B2 (en) * | 2008-09-04 | 2013-05-14 | Boston Scientific Neuromodulation Corporation | Multiple tunable central cathodes on a paddle for increased medial-lateral and rostral-caudal flexibility via current steering |
JP5547200B2 (en) | 2008-10-01 | 2014-07-09 | インスパイア・メディカル・システムズ・インコーポレイテッド | Transvenous treatment to treat sleep apnea |
AU2009302591B2 (en) | 2008-10-09 | 2014-08-07 | Imthera Medical, Inc. | Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
WO2010051499A1 (en) * | 2008-10-31 | 2010-05-06 | Medtronic, Inc. | Therapy system including cardiac rhythm therapy and neurostimulation capabilities |
US8311639B2 (en) | 2009-07-08 | 2012-11-13 | Nevro Corporation | Systems and methods for adjusting electrical therapy based on impedance changes |
WO2010056580A1 (en) | 2008-11-11 | 2010-05-20 | Boston Scientific Neuromodulation Corporation | System and method for increasing relative intensity between cathodes and anodes of neurostimulation system using pulse slicing |
US20100121409A1 (en) * | 2008-11-12 | 2010-05-13 | Sridhar Kothandaraman | System and method for determining appropriate steering tables for distributing stimulation energy among multiple neurostimulation electrodes |
JP2012508624A (en) * | 2008-11-13 | 2012-04-12 | プロテウス バイオメディカル インコーポレイテッド | Multiplexed multiple electrode nerve stimulator |
US20110130809A1 (en) * | 2008-11-13 | 2011-06-02 | Proteus Biomedical, Inc. | Pacing and Stimulation Apparatus and Methods |
EP2349466A4 (en) | 2008-11-13 | 2013-03-20 | Proteus Digital Health Inc | Shielded stimulation and sensing system and method |
US8504160B2 (en) * | 2008-11-14 | 2013-08-06 | Boston Scientific Neuromodulation Corporation | System and method for modulating action potential propagation during spinal cord stimulation |
US9463321B2 (en) * | 2008-11-14 | 2016-10-11 | Boston Scientific Neuromodulation Corporation | System and method for adjusting automatic pulse parameters to selectively activate nerve fibers |
US8583262B2 (en) * | 2008-11-14 | 2013-11-12 | Boston Scientific Neuromodulation Corporation | Implantable medical device that uses electrical current steering by means of output impedance modulation |
EP2346391A4 (en) * | 2008-11-18 | 2012-08-15 | Proteus Biomedical Inc | Sensing system, device, and method for therapy modulation |
US8995731B2 (en) * | 2008-11-26 | 2015-03-31 | Medtronic, Inc. | Image-based characterization of implanted medical leads |
JP2012510340A (en) * | 2008-12-02 | 2012-05-10 | プロテウス バイオメディカル インコーポレイテッド | Communication protocol suitable for the analyzer |
US8380301B2 (en) * | 2008-12-03 | 2013-02-19 | Boston Scientific Neuromodulation Corporation | Method and apparatus for determining relative positioning between neurostimulation leads |
US9623232B2 (en) * | 2008-12-03 | 2017-04-18 | Boston Scientific Neuromodulation Corporation | Method and apparatus for identifying middle lead in a tri-lead configuration |
US20130116745A1 (en) * | 2009-01-15 | 2013-05-09 | Autonomic Technologies, Inc. | Neurostimulator system, apparatus, and method |
US9486628B2 (en) | 2009-03-31 | 2016-11-08 | Inspire Medical Systems, Inc. | Percutaneous access for systems and methods of treating sleep apnea |
EP2414036A4 (en) * | 2009-04-02 | 2013-02-20 | Proteus Digital Health Inc | Method and apparatus for implantable lead |
US9463323B2 (en) | 2009-06-18 | 2016-10-11 | Boston Scientific Neuromodulation Corporation | Spatially selective nerve stimulation in high-frequency nerve conduction block and recruitment |
US9492664B2 (en) * | 2009-06-24 | 2016-11-15 | Boston Scientific Neuromodulation Corporation | System and method for performing percutaneous nerve field stimulation with concurrent anode intensified spinal cord stimulation |
US20100331926A1 (en) * | 2009-06-24 | 2010-12-30 | Boston Scientific Neuromodulation Corporation | Reversing recruitment order by anode intensification |
US8694122B2 (en) | 2009-06-24 | 2014-04-08 | Boston Scientific Neuromodulation Corporation | Symmetrical output neurostimulation device |
US8394102B2 (en) | 2009-06-25 | 2013-03-12 | Baxano, Inc. | Surgical tools for treatment of spinal stenosis |
US9399132B2 (en) | 2009-06-30 | 2016-07-26 | Boston Scientific Neuromodulation Corporation | Method and device for acquiring physiological data during tissue stimulation procedure |
US9345878B2 (en) * | 2009-06-30 | 2016-05-24 | Boston Scientific Neuromodulation Corporation | System and method for compensating for shifting of neurostimulation leads in a patient |
US9737703B2 (en) * | 2009-07-10 | 2017-08-22 | Boston Scientific Neuromodulation Corporation | Method to enhance afferent and efferent transmission using noise resonance |
US8812115B2 (en) * | 2009-07-10 | 2014-08-19 | Boston Scientific Neuromodulation Corporation | System and method for reducing excitability of dorsal root fiber by introducing stochastic background noise |
JP5730872B2 (en) | 2009-07-23 | 2015-06-10 | プロテウス デジタル ヘルス, インコーポレイテッド | Solid thin film capacitor |
CA2772330A1 (en) | 2009-08-27 | 2011-03-03 | The Cleveland Clinic Foundation | System and method to estimate region of tissue activation |
US8543200B2 (en) * | 2009-08-28 | 2013-09-24 | Boston Scientific Neuromodulation Corporation | Methods to avoid frequency locking in a multi-channel neurostimulation system using pulse placement |
US8768481B2 (en) | 2009-08-28 | 2014-07-01 | Boston Scientific Neuromodulation Corporation | Methods to avoid frequency locking in a multi-channel neurostimulation system using a greatest common divisor rule |
US9724513B2 (en) * | 2009-08-28 | 2017-08-08 | Boston Scientific Neuromodulation Corporation | Methods to avoid frequency locking in a multi-channel neurostimulation system using pulse shifting |
US8233992B2 (en) * | 2009-08-28 | 2012-07-31 | Boston Scientific Neuromodulation Corporation | Method and apparatus for determining relative positioning between neurostimulation leads |
US8452414B2 (en) * | 2009-09-29 | 2013-05-28 | Medtronic, Inc. | Steering stimulation current by employing steering current |
WO2011047202A2 (en) | 2009-10-15 | 2011-04-21 | Boston Scientific Neuromodulation Corporation | System and method for modeling electrode morphologies and estimating volume of activation in tissue |
US9327107B2 (en) * | 2009-10-15 | 2016-05-03 | Boston Scientific Neuromodulation Corporation | System and method for modeling electrode morphologies |
US8190250B2 (en) * | 2009-10-15 | 2012-05-29 | Boston Scientific Neuromodulation Corporation | System and method for estimating volume of activation in tissue |
US8744591B2 (en) | 2009-10-21 | 2014-06-03 | Medtronic, Inc. | Storing image of therapy region in implantable medical device |
US9415223B2 (en) * | 2009-11-02 | 2016-08-16 | Boston Scientific Neuromodulation Corporation | Charge recovery bi-phasic control for tissue stimulation |
US8412345B2 (en) * | 2009-11-03 | 2013-04-02 | Boston Scientific Neuromodulation Corporation | System and method for mapping arbitrary electric fields to pre-existing lead electrodes |
US8676308B2 (en) | 2009-11-03 | 2014-03-18 | Boston Scientific Neuromodulation Corporation | System and method for mapping arbitrary electric fields to pre-existing lead electrodes |
JP5764568B2 (en) | 2009-11-09 | 2015-08-19 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Implantable neurostimulator with program creator and method for identifying leads by measuring electronic fingerprint |
JP2013509943A (en) | 2009-11-10 | 2013-03-21 | イムセラ・メディカル・インコーポレーテッド | A system that adjusts the position of the patient's tongue by stimulating the hypoglossal nerve |
US9446231B2 (en) | 2009-11-23 | 2016-09-20 | Boston Scientific Neuromodulation Corporation | Neurostimulation system and method for compounding current to minimize current sources |
US20110125224A1 (en) * | 2009-11-23 | 2011-05-26 | Boston Scientific Neuromodulation Corporation | Neurostimulation system and method for combining current using reconfigurable current sources |
US9352156B2 (en) * | 2009-12-28 | 2016-05-31 | Boston Scientific Neurmodulation Corporation | Automatic evaluation technique for deep brain stimulation programming |
US20110160797A1 (en) * | 2009-12-28 | 2011-06-30 | Boston Scientific Neuromodulation Corporation | Methods to concurrently stimulate different brain targets |
JP2013524947A (en) | 2010-04-19 | 2013-06-20 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Neural stimulation system with means for activating progressive energy transfer |
US9814885B2 (en) | 2010-04-27 | 2017-11-14 | Medtronic, Inc. | Stimulation electrode selection |
WO2011143258A1 (en) | 2010-05-11 | 2011-11-17 | Boston Scientific Neuromodulation Corporation | System and method for defining neurostimulation lead configurations |
US9782592B2 (en) | 2010-07-15 | 2017-10-10 | Boston Scientific Neuromodulation Corporation | Energy efficient high frequency nerve blocking technique |
US8750986B2 (en) | 2010-07-16 | 2014-06-10 | Boston Scientific Neuromodulation Corporation | System and method for estimating clustering of electrodes in neurostimulation system |
US8700165B2 (en) | 2010-07-16 | 2014-04-15 | Boston Scientific Neuromodulation Corporation | System and method for estimating lead configuration from neighboring relationship between electrodes |
US8718780B2 (en) | 2010-08-13 | 2014-05-06 | Boston Scientific Neuromodulation Corporation | System for selectively performing local and radial peripheral stimulation |
AU2011307508A1 (en) | 2010-08-13 | 2013-03-07 | Boston Scientific Neuromodulation Corporation | Neurostimulation system with an interface for changing stimulation parameters by graphical manipulation |
ES2734359T3 (en) | 2010-08-18 | 2019-12-05 | Boston Scient Neuromodulation Corp | User interface for segmented neurostimulation cables |
US20120083857A1 (en) | 2010-10-05 | 2012-04-05 | Boston Scientific Neuromodulation Corporation | Tissue stimulation system and method with anatomy and physiology driven programming |
US9656097B2 (en) | 2010-10-14 | 2017-05-23 | II Erich W. Wolf | Apparatus and method using near infrared reflectometry to reduce the effect of positional changes during spinal cord stimulation |
US9550063B2 (en) | 2010-10-14 | 2017-01-24 | II Erich W. Wolf | Apparatus and method using near infrared reflectometry to reduce the effect of positional changes during spinal cord stimulation |
US9132273B2 (en) | 2010-10-14 | 2015-09-15 | II Erich W. Wolf | Apparatus and method using near infrared reflectometry to reduce the effect of positional changes during spinal cord stimulation |
US8239038B2 (en) * | 2010-10-14 | 2012-08-07 | Wolf Ii Erich W | Apparatus and method using near infrared reflectometry to reduce the effect of positional changes during spinal cord stimulation |
US8718770B2 (en) | 2010-10-21 | 2014-05-06 | Medtronic, Inc. | Capture threshold measurement for selection of pacing vector |
EP2629845B1 (en) | 2010-10-21 | 2016-09-07 | Boston Scientific Neuromodulation Corporation | System for introducing a tissue stimulation lead into a patient using real-time coupling efficiency measurements |
EP2632544A1 (en) | 2010-10-28 | 2013-09-04 | Boston Scientific Neuromodulation Corporation | System and method for providing fluid real-time visualization of region of tissue activation |
US20120109230A1 (en) | 2010-11-03 | 2012-05-03 | Boston Scientific Neuromodulation Corporation | Neurostimulation system and method for graphically displaying electrode stimulation values |
US9713721B2 (en) | 2010-11-10 | 2017-07-25 | Boston Scientific Neuromodulation Corporation | System and method for storing application specific and lead configuration information in neurostimulation device |
AU2011329239A1 (en) | 2010-11-17 | 2013-06-06 | Boston Scientific Neuromodulation Corporation | Implantable neurostimulator-initiated status notification |
WO2012088482A1 (en) | 2010-12-23 | 2012-06-28 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for estimating desired stimulation amplitude for electrode configuration |
WO2012088523A1 (en) | 2010-12-23 | 2012-06-28 | Marvell Asia Pte, Ltd. | Techniques to improve the stress issue in cascode power amplifier design |
US8706250B2 (en) | 2010-12-23 | 2014-04-22 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for implementing model-based estimate of neurostimulation effects |
WO2012092206A1 (en) | 2010-12-27 | 2012-07-05 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for selectively estimating volume of activation and providing therapy |
US9014820B2 (en) | 2011-03-15 | 2015-04-21 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for matching ideal pole spacing with effective electrode separation |
US8868197B2 (en) | 2011-03-15 | 2014-10-21 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for defining ideal multipole configurations at lead boundary |
US8812124B2 (en) | 2011-03-15 | 2014-08-19 | Boston Scientific Neuromodulation Corporation | Neurostimulation system and method for medio-laterally steering current using ideal multipole configurations |
US8909350B2 (en) | 2011-03-15 | 2014-12-09 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for defining a generalized ideal multipole configuration |
US8868196B2 (en) | 2011-03-15 | 2014-10-21 | Boston Scientific Neuromodulation Corporation | Neurostimulation system and method for rostro-caudally steering current using longitudinal ideal multipole configurations |
WO2012125863A2 (en) | 2011-03-15 | 2012-09-20 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for defining a generalized ideal multipole configuration |
US9433795B2 (en) | 2011-04-13 | 2016-09-06 | Boston Scientific Neuromodulation Corporation | User interface with view finder for localizing anatomical region |
US8406890B2 (en) | 2011-04-14 | 2013-03-26 | Medtronic, Inc. | Implantable medical devices storing graphics processing data |
US9123107B2 (en) | 2011-04-28 | 2015-09-01 | Medtronic, Inc. | Image-based analysis of implantable medical device positioning |
CA2835486C (en) | 2011-05-13 | 2022-07-19 | Saluda Medical Pty Limited | Method and apparatus for measurement of neural response - a |
US9974455B2 (en) | 2011-05-13 | 2018-05-22 | Saluda Medical Pty Ltd. | Method and apparatus for estimating neural recruitment |
WO2012158546A2 (en) | 2011-05-13 | 2012-11-22 | Boston Scientific Neuromodulation Corporation | Neurostimulation system with on-effector programmer control |
AU2012255675B2 (en) | 2011-05-13 | 2016-12-01 | Saluda Medical Pty Limited | Method and apparatus for application of a neural stimulus - i |
US8355784B2 (en) | 2011-05-13 | 2013-01-15 | Medtronic, Inc. | Dynamic representation of multipolar leads in a programmer interface |
EP3357533B1 (en) | 2011-05-13 | 2021-08-11 | Saluda Medical Pty Ltd | Apparatus for controlling a neural stimulus |
WO2012155190A1 (en) | 2011-05-13 | 2012-11-22 | National Ict Australia Ltd | Method and apparatus for measurement of neural response |
EP2707090B1 (en) | 2011-05-13 | 2022-05-11 | Boston Scientific Neuromodulation Corporation | Neurostimulation system with means for preventing a stimulation exceeding a limit |
US9872990B2 (en) | 2011-05-13 | 2018-01-23 | Saluda Medical Pty Limited | Method and apparatus for application of a neural stimulus |
US10568559B2 (en) | 2011-05-13 | 2020-02-25 | Saluda Medical Pty Ltd | Method and apparatus for measurement of neural response |
CA2837009A1 (en) | 2011-05-17 | 2012-11-22 | Boston Scientific Neuromodulation Corporation | Display of region of activation in neurostimulation programming screen |
US8849411B2 (en) | 2011-05-17 | 2014-09-30 | Boston Scientific Neuromodulation Corporation | User-defined graphical shapes used as a visualization aid for stimulator programming |
US20120300953A1 (en) | 2011-05-24 | 2012-11-29 | Herbert Mauch | Integrity evaluation system in an implantable hearing prosthesis |
ES2900585T3 (en) | 2011-05-27 | 2022-03-17 | Boston Scient Neuromodulation Corp | Collection of clinical data for graphic representation and analysis |
US8700180B2 (en) | 2011-06-23 | 2014-04-15 | Boston Scientific Neuromodulation Corporation | Method for improving far-field activation in peripheral field nerve stimulation |
US9511229B2 (en) | 2011-06-28 | 2016-12-06 | Boston Scientific Neuromodulation Corporation | System and method for using impedance to determine proximity and orientation of segmented electrodes |
US9814884B2 (en) | 2011-11-04 | 2017-11-14 | Nevro Corp. | Systems and methods for detecting faults and/or adjusting electrical therapy based on impedance changes |
WO2013075019A1 (en) | 2011-11-18 | 2013-05-23 | Boston Scientific Neuromodulation Corporation | Technique for linking electrodes together during programming of neurostimulation system |
FR2982758B1 (en) | 2011-11-21 | 2013-11-15 | Impeto Medical | PHYSIOLOGICAL ANALYSIS METHOD OF INCREASED RELIABILITY |
WO2013086215A1 (en) | 2011-12-08 | 2013-06-13 | Boston Scientific Neuromodulation Corporation | System and method for automatically training a neurostimulation system |
US8660653B2 (en) | 2011-12-16 | 2014-02-25 | Boston Scientific Neuromodulation Corporation | Seamless integration of different programming modes for a neurostimulator programming system |
US8594797B2 (en) | 2011-12-19 | 2013-11-26 | Boston Scientific Neuromodulation Corporation | Computationally efficient technique for determining electrode current distribution from a virtual multipole |
US20150018728A1 (en) | 2012-01-26 | 2015-01-15 | Bluewind Medical Ltd. | Wireless neurostimulators |
EP2825253A1 (en) | 2012-03-16 | 2015-01-21 | Boston Scientific Neuromodulation Corporation | Field augmented current steering using voltage sources |
WO2013138305A2 (en) | 2012-03-16 | 2013-09-19 | Boston Scientific Neuromodulation Corporation | System and method for estimating location and depth of stimulation leads |
WO2013138511A1 (en) | 2012-03-16 | 2013-09-19 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for preventing magnetically induced currents in electronic circuitry |
ES2577983T3 (en) | 2012-03-23 | 2016-07-19 | Boston Scientific Neuromodulation Corporation | Heuristic safety net for the transition of configurations in a neurostimulation system |
JP5957140B2 (en) | 2012-04-06 | 2016-07-27 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Nerve stimulation system and method for configuring a stimulation program |
US9002465B2 (en) | 2012-04-06 | 2015-04-07 | Boston Scientific Neuromodulation Corporation | Verifying correct operation of an implantable neurostimulator device using current distribution circuitry |
WO2013158667A1 (en) | 2012-04-17 | 2013-10-24 | Boston Scientific Neuromodulation Corporation | Neurostimulation device having frequency selective surface to prevent electromagnetic interference during mri |
EP2841152A1 (en) | 2012-04-27 | 2015-03-04 | Boston Scientific Neuromodulation Corporation | Timing channel circuitry for creating pulses in an implantable stimulator device |
US10588543B2 (en) * | 2012-05-23 | 2020-03-17 | Biosense Webster (Israel), Ltd. | Position sensing using electric dipole fields |
US9095712B2 (en) | 2012-05-29 | 2015-08-04 | Boston Scientific Neuromodulation Corporation | Electrical stimulation method for modulation on sensory information around dorsal root ganglia |
AU2013271835A1 (en) | 2012-06-05 | 2014-09-18 | Boston Scientific Neuromodulation Corporation | Neurostimulation system with default MRI-mode |
CA2870061A1 (en) | 2012-06-25 | 2014-01-03 | Boston Scientific Neuromodulation Corporation | Neurostimulation system for enabling magnetic field sensing with a shut-down hall sensor |
WO2014005024A1 (en) | 2012-06-29 | 2014-01-03 | Boston Scientific Neuromodulation Corporation | High frequency neuromodulation system for reducing energy requirements |
US9084900B2 (en) | 2012-06-29 | 2015-07-21 | Boston Scientific Neuromodulation Corporation | Neuromodulation system and method for reducing energy requirements using feedback |
US9339655B2 (en) | 2012-06-30 | 2016-05-17 | Boston Scientific Neuromodulation Corporation | System and method for compounding low-frequency sources for high-frequency neuromodulation |
US20140031908A1 (en) | 2012-07-27 | 2014-01-30 | Boston Scientific Neuromodulation Corporation | System and method for enhancing large diameter nerve fiber stimulation using sequential activation of electrodes |
US8825172B2 (en) | 2012-07-27 | 2014-09-02 | Boston Scientific Neuromodulation Corporation | Techniques for electronically assessing electrode condition and peri-electrode tissue conductivity change pre- and post-MRI |
US10828495B2 (en) | 2012-08-29 | 2020-11-10 | Boston Scientific Neuromodulation Corporation | System and method for identifying availability of clinician defined programming settings for a patient |
US9002459B2 (en) | 2012-09-19 | 2015-04-07 | Boston Scientific Neuromodulation Corporation | Method for selectively modulating neural elements in the dorsal horn |
WO2014055328A1 (en) | 2012-10-03 | 2014-04-10 | Boston Scientific Neuromodulation Corporation | Micro-electrode recording-guided implantation of directional leads |
WO2014058649A1 (en) | 2012-10-10 | 2014-04-17 | Boston Scientific Neuromodulation Corporation | Neurostimulation programmer and method for globally assigning parameter values to electrodes |
WO2014058650A1 (en) | 2012-10-10 | 2014-04-17 | Boston Scientific Neuromodulation Corporation | Neurostimulation programmer and method for directly assigning parameter values to electrodes |
DK2908904T3 (en) | 2012-11-06 | 2020-12-14 | Saluda Medical Pty Ltd | SYSTEM FOR CONTROLING THE ELECTRICAL CONDITION OF TISSUE |
CN105142529A (en) | 2012-11-21 | 2015-12-09 | 电路治疗公司 | System and method for optogenetic therapy |
WO2014087337A1 (en) | 2012-12-06 | 2014-06-12 | Bluewind Medical Ltd. | Delivery of implantable neurostimulators |
US9089705B2 (en) | 2012-12-07 | 2015-07-28 | Boston Scientific Neuromodulation Corporation | Neurostimulation system with three-dimensional lead migration detection and automatic neurostimulation correction |
US9446243B2 (en) | 2012-12-07 | 2016-09-20 | Boston Scientific Neuromodulation Corporation | Patient posture determination and stimulation program adjustment in an implantable stimulator device using impedance fingerprinting |
US9656089B2 (en) | 2012-12-14 | 2017-05-23 | Boston Scientific Neuromodulation Corporation | Method for automation of therapy-based programming in a tissue stimulator user interface |
US9421376B2 (en) | 2012-12-21 | 2016-08-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for adjusting electrical neuromodulation therapy in medication therapeutic window |
US9295840B1 (en) | 2013-01-22 | 2016-03-29 | Nevro Corporation | Systems and methods for automatically programming patient therapy devices |
US9895538B1 (en) | 2013-01-22 | 2018-02-20 | Nevro Corp. | Systems and methods for deploying patient therapy devices |
AU2014218709B2 (en) | 2013-02-22 | 2018-05-10 | Boston Scientific Neuromodulation Corporation | Multi-channel neuromodulation system with means for combining pulse trains |
US9533148B2 (en) | 2013-02-22 | 2017-01-03 | Boston Scientific Neuromodulation Corporation | Neurostimulation system and method for automatically adjusting stimulation and reducing energy requirements using evoked action potential |
US9358391B2 (en) | 2013-02-22 | 2016-06-07 | Boston Scientific Neuromodulation Corporation | Neurostimulation system having increased flexibility for creating complex pulse trains |
US9095724B2 (en) | 2013-02-25 | 2015-08-04 | Boston Scientific Neuromodulation Corporation | Neuromodulation system with dual telemetry system |
US9174053B2 (en) | 2013-03-08 | 2015-11-03 | Boston Scientific Neuromodulation Corporation | Neuromodulation using modulated pulse train |
US9440076B2 (en) | 2013-03-15 | 2016-09-13 | Globus Medical, Inc. | Spinal cord stimulator system |
US9872997B2 (en) | 2013-03-15 | 2018-01-23 | Globus Medical, Inc. | Spinal cord stimulator system |
US10232181B2 (en) | 2013-03-15 | 2019-03-19 | Boston Scientific Neuromodulation Corporation | Techniques for current steering directional programming in a neurostimulation system |
US9314639B2 (en) | 2013-03-15 | 2016-04-19 | Boston Scientific Neuromodulation Corporation | Techniques for logging and using programming history in a neurostimulation system |
EP3884995B1 (en) | 2013-03-15 | 2023-07-26 | Boston Scientific Neuromodulation Corporation | Systems for delivering sub-threshold therapy to a patient |
US9878170B2 (en) | 2013-03-15 | 2018-01-30 | Globus Medical, Inc. | Spinal cord stimulator system |
US9694183B2 (en) | 2013-03-15 | 2017-07-04 | Boston Scientific Neuromodulation Corporation | Neuromodulation system and method for providing multiple modulation patterns in a single channel |
US9887574B2 (en) | 2013-03-15 | 2018-02-06 | Globus Medical, Inc. | Spinal cord stimulator system |
EP2981329B1 (en) | 2013-04-04 | 2019-05-29 | Boston Scientific Neuromodulation Corporation | Management of stimulation safety limits in a neurostimulation system |
US9180297B2 (en) | 2013-05-16 | 2015-11-10 | Boston Scientific Neuromodulation Corporation | System and method for spinal cord modulation to treat motor disorder without paresthesia |
WO2014197564A1 (en) | 2013-06-06 | 2014-12-11 | Boston Scientific Neuromodulation Corporation | System for delivering sub-threshold and super-threshold therapy |
EP3003472B1 (en) | 2013-06-06 | 2021-07-28 | Que T. Doan | System for delivering modulated sub-threshold therapy |
AU2014302297B2 (en) | 2013-06-28 | 2017-04-13 | Boston Scientific Neuromodulation Corporation | Electrode selection for sub-threshold modulation therapy |
US9242085B2 (en) | 2013-06-28 | 2016-01-26 | Boston Scientific Neuromodulation Corporation | Transcutaneous electrical stimulation for treating neurological disorders |
US9539422B2 (en) * | 2013-07-02 | 2017-01-10 | Greatbatch Ltd. | Neurostimulator interconnection apparatus, system, and method |
JP6181307B2 (en) | 2013-07-26 | 2017-08-16 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | A system that provides modulation therapy without perception |
WO2015031136A1 (en) | 2013-08-29 | 2015-03-05 | Boston Scientific Neuromodulation Corporation | Systems for adjusting the compliance voltage in a neuromodulation device |
US9496733B2 (en) | 2013-09-13 | 2016-11-15 | Boston Scientific Neuromodulation Corporation | Optical communications between an implantable medical device and external charger |
AU2014342534B9 (en) | 2013-10-30 | 2018-01-25 | Boston Scientific Neuromodulation Corporation | Fractional control to avoid dorsal root stimulation |
CN105682734B (en) | 2013-10-31 | 2018-08-17 | 波士顿科学神经调制公司 | System for being incorporated to the lead information from image |
JP6339194B2 (en) | 2013-11-01 | 2018-06-06 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | System for delivering subthreshold treatment at the midline |
EP3068296A4 (en) | 2013-11-15 | 2017-07-19 | Saluda Medical Pty Limited | Monitoring brain neural potentials |
EP3071100B1 (en) | 2013-11-22 | 2024-01-03 | Saluda Medical Pty Limited | Method and device for detecting a neural response in a neural measurement |
US10010715B2 (en) | 2013-12-04 | 2018-07-03 | Boston Scientific Neuromodulation Corporation | Systems and methods for delivering therapy to the dorsal horn of a patient |
ES2481515B1 (en) * | 2013-12-12 | 2015-02-27 | Indiba, S.A. | Electrotherapy device |
US9616230B2 (en) | 2013-12-12 | 2017-04-11 | Boston Scientific Neuromodulation Corporation | Systems and methods for programming a neuromodulation system |
US9381360B2 (en) | 2014-02-05 | 2016-07-05 | Boston Scientific Neuromodulation Corporation | System and method for delivering modulated sub-threshold therapy to a patient |
JP2017517315A (en) | 2014-02-05 | 2017-06-29 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | System and method for performing sub-modulation threshold therapy on a patient |
WO2015123360A1 (en) | 2014-02-11 | 2015-08-20 | Cyberonics, Inc. | Systems and methods of detecting and treating obstructive sleep apnea |
US9421379B2 (en) | 2014-02-25 | 2016-08-23 | Boston Scientific Neuromodulation Corporation | Neuromodulation system incorporating multivariate sensing, multivariable pattern recognition, and patient specific adaptation |
CN106456978B (en) | 2014-04-25 | 2019-01-11 | 波士顿科学神经调制公司 | The system and method for electric pulse charge compensation for implantable medical device capacitive load effect |
WO2015168735A1 (en) | 2014-05-05 | 2015-11-12 | Saluda Medical Pty Ltd | Improved neural measurement |
JP6437019B2 (en) | 2014-07-03 | 2018-12-12 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Nerve stimulation system with flexible pattern formation and waveform |
EP3171927B1 (en) | 2014-07-24 | 2020-07-15 | Boston Scientific Neuromodulation Corporation | Enhanced dorsal horn stimulation using multiple electrical fields |
ES2873255T3 (en) | 2014-07-25 | 2021-11-03 | Saluda Medical Pty Ltd | Neurological stimulation dosage |
EP3461532B1 (en) | 2014-09-15 | 2022-12-28 | Boston Scientific Neuromodulation Corporation | Graphical user interface for programming neurostimulation pulse patterns |
AU2015321559B2 (en) | 2014-09-23 | 2018-09-13 | Boston Scientific Neuromodulation Corporation | Neuromodulation specific to objective function of modulation field for targeted tissue |
US9993646B2 (en) | 2014-09-23 | 2018-06-12 | Boston Scientific Neuromodulation Corporation | Sub-perception modulation responsive to patient input |
JP6621812B2 (en) | 2014-09-23 | 2019-12-18 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | Sensory calibration of neural tissue using field trawl |
US10471260B2 (en) | 2014-09-23 | 2019-11-12 | Boston Scientific Neuromodulation Corporation | Method and apparatus for calibrating dorsal horn stimulation using sensors |
WO2016048965A1 (en) | 2014-09-23 | 2016-03-31 | Boston Scientific Neuromodulation Corporation | Neuromodulation with burst stimulation |
AU2015321491B2 (en) | 2014-09-23 | 2018-09-27 | Boston Scientific Neuromodulation Corporation | Short pulse width stimulation |
US9656085B2 (en) | 2014-09-23 | 2017-05-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for receiving user-provided selection of electrode lists |
AU2015343483B2 (en) | 2014-11-04 | 2018-03-01 | Boston Scientific Neuromodulation Corporation | Method and apparatus for programming complex neurostimulation patterns |
WO2016077882A1 (en) | 2014-11-17 | 2016-05-26 | Saluda Medical Pty Ltd | Method and device for detecting a neural response in neural measurements |
US10588698B2 (en) | 2014-12-11 | 2020-03-17 | Saluda Medical Pty Ltd | Implantable electrode positioning |
WO2016090436A1 (en) | 2014-12-11 | 2016-06-16 | Saluda Medical Pty Ltd | Method and device for feedback control of neural stimulation |
EP3229893B1 (en) | 2015-01-19 | 2020-06-17 | Saluda Medical Pty Ltd | Method and device for neural implant communication |
CN107405484B (en) | 2015-02-09 | 2021-09-24 | 波士顿科学神经调制公司 | System for determining a neural location of an epidural lead |
US10596379B2 (en) | 2015-02-16 | 2020-03-24 | Newronika S.r.l. | Apparatus and method for treating neurological disorders |
WO2016161484A2 (en) | 2015-04-09 | 2016-10-13 | Saluda Medical Pty Ltd | Electrode to nerve distance estimation |
AU2016268007B2 (en) | 2015-05-28 | 2019-04-18 | Boston Scientific Neuromodulation Corporation | Neuromodulation using stochastically-modulated stimulation parameters |
WO2016191808A1 (en) | 2015-05-31 | 2016-12-08 | Saluda Medical Pty Ltd | Monitoring brain neural activity |
CA2983333C (en) | 2015-05-31 | 2023-09-19 | Saluda Medical Pty Ltd | Brain neurostimulator electrode fitting |
CN107613861B (en) | 2015-06-01 | 2021-10-26 | 闭环医疗私人有限公司 | Motor fiber neuromodulation |
WO2017019191A1 (en) | 2015-07-30 | 2017-02-02 | Boston Scientific Neuromodulation Corporation | User interface for custom patterned electrical stimulation |
JP6624704B2 (en) | 2015-08-31 | 2019-12-25 | 日立化成株式会社 | Molecular methods for assessing urothelial disease |
CN108463266B (en) | 2015-10-15 | 2021-10-08 | 波士顿科学神经调制公司 | User interface for neurostimulation waveform construction |
US10105540B2 (en) | 2015-11-09 | 2018-10-23 | Bluewind Medical Ltd. | Optimization of application of current |
US10300277B1 (en) | 2015-12-14 | 2019-05-28 | Nevro Corp. | Variable amplitude signals for neurological therapy, and associated systems and methods |
WO2017125274A1 (en) | 2016-01-20 | 2017-07-27 | Sorin Crm Sas | Active implantable medical neurostimulation device with sectoral electrodes that are switchable according to various configurations |
US10335607B2 (en) | 2016-02-05 | 2019-07-02 | Boston Scientific Neuromodulation Corporation | Implantable optical stimulation lead and methods of making and using |
US10786674B2 (en) | 2016-03-08 | 2020-09-29 | Medtronic, Inc. | Medical therapy target definition |
WO2017165410A1 (en) | 2016-03-21 | 2017-09-28 | Nalu Medical, Inc. | Devices and methods for positioning external devices in relation to implanted devices |
CA3019701A1 (en) | 2016-04-05 | 2017-10-12 | Saluda Medical Pty Ltd | Improved feedback control of neuromodulation |
JP7278076B2 (en) | 2016-06-24 | 2023-05-19 | サルーダ・メディカル・ピーティーワイ・リミテッド | Nerve stimulation to reduce artifacts |
EP3484577A4 (en) | 2016-07-18 | 2020-03-25 | Nalu Medical, Inc. | Methods and systems for treating pelvic disorders and pain conditions |
WO2018039117A1 (en) | 2016-08-22 | 2018-03-01 | Boston Scientific Neuromodulation Corporation | Neuromodulation system for providing paresthesia and analgesia and a system with leads and with electrodes |
US10625072B2 (en) | 2016-10-21 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Electrical stimulation methods with optical observation and devices therefor |
US10124178B2 (en) | 2016-11-23 | 2018-11-13 | Bluewind Medical Ltd. | Implant and delivery tool therefor |
EP3585475B1 (en) | 2017-02-24 | 2024-04-03 | Nalu Medical, Inc. | Apparatus with sequentially implanted stimulators |
US20180353764A1 (en) | 2017-06-13 | 2018-12-13 | Bluewind Medical Ltd. | Antenna configuration |
US10814140B2 (en) | 2017-06-26 | 2020-10-27 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and controlling optogenetic stimulation using optical stimulation systems |
WO2019055812A1 (en) | 2017-09-15 | 2019-03-21 | Boston Scientific Neuromodulation Corporation | Current generation architecture for an implantable stimulator device including distributor circuitry for sending an amplitude-scaled current to digital-to-analog converters at the electrodes |
AU2018222994B2 (en) * | 2017-09-15 | 2019-11-07 | Boston Scientific Neuromodulation Corporation | Current generation architecture for an implantable stimulator device to promote current steering between electrodes |
WO2019139883A1 (en) | 2018-01-11 | 2019-07-18 | Boston Scientific Neuromodulation Corporation | Methods and systems for stimulation for glial modulation |
IT201800002962A1 (en) | 2018-02-22 | 2019-08-22 | Newronika Srl | APPARATUS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS USING ELECTROSTIMULATION AND METHOD OF PROCESSING THE NEUROLOGICAL SIGNAL COLLECTED BY THIS APP |
EP3768372A1 (en) | 2018-03-23 | 2021-01-27 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making and using |
WO2019183054A1 (en) | 2018-03-23 | 2019-09-26 | Boston Scientific Neuromodulation Corporation | Optical stimulation systems with calibration and methods of making and using |
JP2021521985A (en) | 2018-04-27 | 2021-08-30 | サルーダ・メディカル・ピーティーワイ・リミテッド | Nerve stimulation of mixed nerves |
EP3813932B1 (en) * | 2018-06-27 | 2022-06-29 | Boston Scientific Neuromodulation Corporation | Stimulation field modelling in an implantable stimulator device |
US11224743B2 (en) | 2018-09-21 | 2022-01-18 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using modular leads for electrical stimulation systems |
US11566885B2 (en) | 2018-10-31 | 2023-01-31 | Biotronik Se & Co. Kg | Method for relative lead offset determination |
AU2019378702B2 (en) | 2018-11-16 | 2022-09-01 | Boston Scientific Neuromodulation Corporation | An optical stimulation system with on-demand monitoring and methods of making |
US11318309B2 (en) | 2018-12-13 | 2022-05-03 | Newronika S.P.A. | Method and apparatus for treating Tourette Syndrome by brain stimulation |
EP3976170A1 (en) | 2019-05-30 | 2022-04-06 | Boston Scientific Neuromodulation Corporation | Methods and systems for discrete measurement of electrical characteristics |
AU2020298313B2 (en) | 2019-06-20 | 2023-06-08 | Boston Scientific Neuromodulation Corporation | Methods and systems for interleaving waveforms for electrical stimulation and measurement |
WO2021133947A1 (en) * | 2019-12-23 | 2021-07-01 | Nalu Medical, Inc. | Systems with implanted conduit tracking |
EP4168110A1 (en) | 2020-09-04 | 2023-04-26 | Boston Scientific Neuromodulation Corporation | Stimulation systems with a lens arrangement for light coupling and methods of making and using |
US11529517B2 (en) * | 2020-09-29 | 2022-12-20 | Medtronic, Inc. | Electrode movement detection |
US11975200B2 (en) | 2021-02-24 | 2024-05-07 | Medtronic, Inc. | Directional stimulation programming |
WO2022217184A1 (en) | 2021-04-06 | 2022-10-13 | Boston Scientific Neuromodulation Corporation | Current generation architecture for an implantable stimulator device |
WO2023030889A1 (en) * | 2021-09-02 | 2023-03-09 | Biotronik Se & Co. Kg | Method to check a medical device and method of operating the same |
US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876336A (en) * | 1994-10-11 | 1999-03-02 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structure |
US5964796A (en) * | 1993-09-24 | 1999-10-12 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-port introducer for use therewith |
US6038468A (en) * | 1997-09-26 | 2000-03-14 | Roke Manor Research Ltd. | Catheter localisation system |
US6106460A (en) * | 1998-03-26 | 2000-08-22 | Scimed Life Systems, Inc. | Interface for controlling the display of images of diagnostic or therapeutic instruments in interior body regions and related data |
US20010034542A1 (en) * | 1999-12-17 | 2001-10-25 | Mann Carla M. | Magnitude programming for implantable electrical stimulator |
US6393325B1 (en) * | 1999-01-07 | 2002-05-21 | Advanced Bionics Corporation | Directional programming for implantable electrode arrays |
US6640119B1 (en) * | 1992-09-23 | 2003-10-28 | Endocardial Solutions, Inc. | Method for orienting an electrode array |
US20040143303A1 (en) * | 2002-10-31 | 2004-07-22 | Sieracki Jeffrey M. | Applying filter information to identify combinations of electrodes |
US20040199218A1 (en) * | 2003-04-02 | 2004-10-07 | Lee Michael T. | Library for management of neurostimulation therapy programs |
US20060122654A1 (en) * | 2001-12-04 | 2006-06-08 | Kerry Bradley | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US20090306746A1 (en) * | 2006-02-07 | 2009-12-10 | Brian Blischak | System and method for programming an implantable neurostimulator |
US20100305631A1 (en) * | 2001-12-04 | 2010-12-02 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3646940A (en) | 1969-07-15 | 1972-03-07 | Univ Minnesota | Implantable electronic stimulator electrode and method |
US3724467A (en) | 1971-04-23 | 1973-04-03 | Avery Labor Inc | Electrode implant for the neuro-stimulation of the spinal cord |
US3822708A (en) * | 1972-12-07 | 1974-07-09 | Clinical Technology Corp | Electrical spinal cord stimulating device and method for management of pain |
US3811708A (en) * | 1973-02-13 | 1974-05-21 | Us Army | Trailer hitch |
IL62861A (en) * | 1981-05-13 | 1988-01-31 | Yeda Res & Dev | Method and apparatus for carrying out electric tomography |
CA1196691A (en) * | 1982-01-12 | 1985-11-12 | Bradley Fry | Reconstruction system and methods for impedance imaging |
US4735204A (en) * | 1984-09-17 | 1988-04-05 | Cordis Corporation | System for controlling an implanted neural stimulator |
US5184624A (en) * | 1988-04-15 | 1993-02-09 | The University Of Sheffield | Electrical impedance tomography |
US4911174A (en) * | 1989-02-13 | 1990-03-27 | Cardiac Pacemakers, Inc. | Method for matching the sense length of an impedance measuring catheter to a ventricular chamber |
US5201865A (en) * | 1991-10-28 | 1993-04-13 | Medtronic, Inc. | Medical lead impedance measurement system |
US5333618A (en) | 1993-06-30 | 1994-08-02 | Gregory Lekhtman | Portable self-contained instrument for the measurement of nerve resistance of a patient |
US5722402A (en) * | 1994-10-11 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structures |
US5702429A (en) | 1996-04-04 | 1997-12-30 | Medtronic, Inc. | Neural stimulation techniques with feedback |
US6913763B2 (en) * | 1996-11-19 | 2005-07-05 | Intrabrain International Nv | Method and device for enhanced delivery of a biologically active agent through the spinal spaces into the central nervous system of a mammal |
US5735887A (en) * | 1996-12-10 | 1998-04-07 | Exonix Corporation | Closed-loop, RF-coupled implanted medical device |
US5895416A (en) * | 1997-03-12 | 1999-04-20 | Medtronic, Inc. | Method and apparatus for controlling and steering an electric field |
US5941906A (en) | 1997-10-15 | 1999-08-24 | Medtronic, Inc. | Implantable, modular tissue stimulator |
US6181969B1 (en) * | 1998-06-26 | 2001-01-30 | Advanced Bionics Corporation | Programmable current output stimulus stage for implantable device |
US6027456A (en) | 1998-07-10 | 2000-02-22 | Advanced Neuromodulation Systems, Inc. | Apparatus and method for positioning spinal cord stimulation leads |
US6052624A (en) | 1999-01-07 | 2000-04-18 | Advanced Bionics Corporation | Directional programming for implantable electrode arrays |
US6353762B1 (en) * | 1999-04-30 | 2002-03-05 | Medtronic, Inc. | Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve |
US6516227B1 (en) | 1999-07-27 | 2003-02-04 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
US6609029B1 (en) | 2000-02-04 | 2003-08-19 | Advanced Bionics Corporation | Clip lock mechanism for retaining lead |
US6741892B1 (en) | 2000-03-10 | 2004-05-25 | Advanced Bionics Corporation | Movable contact locking mechanism for spinal cord stimulator lead connector |
ES2467916T3 (en) | 2000-07-26 | 2014-06-13 | Boston Scientific Neuromodulation Corporation | Rechargeable stimulator system |
US6662053B2 (en) * | 2000-08-17 | 2003-12-09 | William N. Borkan | Multichannel stimulator electronics and methods |
US6845267B2 (en) | 2000-09-28 | 2005-01-18 | Advanced Bionics Corporation | Systems and methods for modulation of circulatory perfusion by electrical and/or drug stimulation |
US7283874B2 (en) * | 2000-10-16 | 2007-10-16 | Remon Medical Technologies Ltd. | Acoustically powered implantable stimulating device |
US6675049B2 (en) | 2001-07-17 | 2004-01-06 | Medtronic, Inc. | Method and apparatus for automatic implantable medical lead recognition and configuration |
CA2459408A1 (en) | 2001-08-28 | 2003-03-13 | Medtronic, Inc. | Medical device for treating cardiac mechanical dysfunction by electrical stimulation |
ES2340271T3 (en) | 2002-12-06 | 2010-06-01 | Boston Scientific Neuromodulation Corporation | METHOD FOR DETERMINING STIMULATION PARAMETERS. |
-
2002
- 2002-12-03 US US10/310,202 patent/US6993384B2/en not_active Expired - Lifetime
-
2006
- 2006-01-30 US US11/343,007 patent/US8682447B2/en active Active
- 2006-01-30 US US11/342,989 patent/US7684869B2/en active Active
-
2009
- 2009-06-02 US US12/476,951 patent/US20090248118A1/en not_active Abandoned
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6640119B1 (en) * | 1992-09-23 | 2003-10-28 | Endocardial Solutions, Inc. | Method for orienting an electrode array |
US5964796A (en) * | 1993-09-24 | 1999-10-12 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-port introducer for use therewith |
US5876336A (en) * | 1994-10-11 | 1999-03-02 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structure |
US6038468A (en) * | 1997-09-26 | 2000-03-14 | Roke Manor Research Ltd. | Catheter localisation system |
US6106460A (en) * | 1998-03-26 | 2000-08-22 | Scimed Life Systems, Inc. | Interface for controlling the display of images of diagnostic or therapeutic instruments in interior body regions and related data |
US6393325B1 (en) * | 1999-01-07 | 2002-05-21 | Advanced Bionics Corporation | Directional programming for implantable electrode arrays |
US20010034542A1 (en) * | 1999-12-17 | 2001-10-25 | Mann Carla M. | Magnitude programming for implantable electrical stimulator |
US20060122654A1 (en) * | 2001-12-04 | 2006-06-08 | Kerry Bradley | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US7684869B2 (en) * | 2001-12-04 | 2010-03-23 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US20100305631A1 (en) * | 2001-12-04 | 2010-12-02 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US7853330B2 (en) * | 2001-12-04 | 2010-12-14 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US20040143303A1 (en) * | 2002-10-31 | 2004-07-22 | Sieracki Jeffrey M. | Applying filter information to identify combinations of electrodes |
US20040199218A1 (en) * | 2003-04-02 | 2004-10-07 | Lee Michael T. | Library for management of neurostimulation therapy programs |
US20090306746A1 (en) * | 2006-02-07 | 2009-12-10 | Brian Blischak | System and method for programming an implantable neurostimulator |
Cited By (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100305631A1 (en) * | 2001-12-04 | 2010-12-02 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US10022540B2 (en) | 2001-12-04 | 2018-07-17 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US9192760B2 (en) | 2001-12-04 | 2015-11-24 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US9610439B2 (en) | 2001-12-04 | 2017-04-04 | Boston Scientific Neuromodulation Corporation | Apparatus and method for determining the relative position and orientation of neurostimulation leads |
US20090253977A1 (en) * | 2003-10-21 | 2009-10-08 | Kipke Daryl R | Intracranial neural interface system |
US8412302B2 (en) | 2003-10-21 | 2013-04-02 | The Regents Of The University Of Michigan | Intracranial neural interface system |
US20110046470A1 (en) * | 2003-10-21 | 2011-02-24 | Kipke Daryl R | Intracranial neural interface system |
US7979105B2 (en) | 2003-10-21 | 2011-07-12 | The Regents Of The University Of Michigan | Intracranial neural interface system |
US8078252B2 (en) | 2003-10-21 | 2011-12-13 | Kipke Daryl R | Intracranial neural interface system |
US9014796B2 (en) | 2005-06-14 | 2015-04-21 | Regents Of The University Of Michigan | Flexible polymer microelectrode with fluid delivery capability and methods for making same |
US8800140B2 (en) | 2005-10-07 | 2014-08-12 | Neuronexus Technologies, Inc. | Method of making a modular multichannel microelectrode array |
US20070123765A1 (en) * | 2005-10-07 | 2007-05-31 | Hetke Jamille F | Modular multichannel microelectrode array and methods of making same |
US7941202B2 (en) | 2005-10-07 | 2011-05-10 | Neuronexus Technologies | Modular multichannel microelectrode array and methods of making same |
US20110154655A1 (en) * | 2005-10-07 | 2011-06-30 | Hetke Jamille F | Modular multichannel microelectrode array and methods of making same |
US8195267B2 (en) | 2006-01-26 | 2012-06-05 | Seymour John P | Microelectrode with laterally extending platform for reduction of tissue encapsulation |
US20090299167A1 (en) * | 2006-01-26 | 2009-12-03 | Seymour John P | Microelectrode with laterally extending platform for reduction of tissue encapsulation |
US8463353B2 (en) | 2006-01-26 | 2013-06-11 | The Regents Of The University Of Michigan | Microelectrode with laterally extending platform for reduction of tissue encapsulation |
US9604051B2 (en) | 2007-02-26 | 2017-03-28 | Medtronic Bakken Research Center B.V. | Neural interface system |
US10357649B2 (en) | 2007-02-26 | 2019-07-23 | Medtronic Bakken Research Center B.V. | Neural interface system |
US11324945B2 (en) | 2007-02-26 | 2022-05-10 | Medtronic Bakken Research Center B.V. | Neural interface system |
US8731673B2 (en) | 2007-02-26 | 2014-05-20 | Sapiens Steering Brain Stimulation B.V. | Neural interface system |
US10034615B2 (en) | 2007-10-17 | 2018-07-31 | Neuronexus Technologies, Inc. | Method for implanting an implantable device in body tissue |
US8565894B2 (en) | 2007-10-17 | 2013-10-22 | Neuronexus Technologies, Inc. | Three-dimensional system of electrode leads |
US8224417B2 (en) | 2007-10-17 | 2012-07-17 | Neuronexus Technologies, Inc. | Guide tube for an implantable device system |
US8958862B2 (en) | 2007-10-17 | 2015-02-17 | Neuronexus Technologies, Inc. | Implantable device including a resorbable carrier |
US11690548B2 (en) | 2007-10-17 | 2023-07-04 | Neuronexus Technologies, Inc. | Method for implanting an implantable device in body tissue |
US8805468B2 (en) | 2007-10-17 | 2014-08-12 | Neuronexus Technologies, Inc. | Guide tube for an implantable device system |
US20090187196A1 (en) * | 2007-10-17 | 2009-07-23 | Vetter Rio J | Guide tube for an implantable device system |
US20090118806A1 (en) * | 2007-10-17 | 2009-05-07 | Vetter Rio J | Three-dimensional system of electrode leads |
US9265928B2 (en) | 2008-02-29 | 2016-02-23 | Greatbatch Ltd. | Implantable electrode and method of making the same |
US10688298B2 (en) | 2008-02-29 | 2020-06-23 | Neuronexus Technologies, Inc. | Implantable electrode and method of making the same |
US9656054B2 (en) | 2008-02-29 | 2017-05-23 | Neuronexus Technologies, Inc. | Implantable electrode and method of making the same |
US8498720B2 (en) | 2008-02-29 | 2013-07-30 | Neuronexus Technologies, Inc. | Implantable electrode and method of making the same |
US9289142B2 (en) | 2008-03-24 | 2016-03-22 | Neuronexus Technologies, Inc. | Implantable electrode lead system with a three dimensional arrangement and method of making the same |
US20090240314A1 (en) * | 2008-03-24 | 2009-09-24 | Kong K C | Implantable electrode lead system with a three dimensional arrangement and method of making the same |
US9403020B2 (en) | 2008-11-04 | 2016-08-02 | Nevro Corporation | Modeling positions of implanted devices in a patient |
US8332046B2 (en) | 2009-10-16 | 2012-12-11 | Neuronexus Technologies, Inc. | Neural interface system |
US20110093052A1 (en) * | 2009-10-16 | 2011-04-21 | Anderson David J | Neural interface system |
US9643027B2 (en) | 2009-11-05 | 2017-05-09 | Neuronexus Technologies, Inc. | Waveguide neural interface device |
US20110112591A1 (en) * | 2009-11-05 | 2011-05-12 | Seymour John P | Waveguide neural interface device |
US8870857B2 (en) | 2009-11-05 | 2014-10-28 | Greatbatch Ltd. | Waveguide neural interface device |
US9155861B2 (en) | 2010-09-20 | 2015-10-13 | Neuronexus Technologies, Inc. | Neural drug delivery system with fluidic threads |
US8805519B2 (en) | 2010-09-30 | 2014-08-12 | Nevro Corporation | Systems and methods for detecting intrathecal penetration |
WO2012044699A3 (en) * | 2010-09-30 | 2014-04-03 | Nevro Corporation | Systems and methods for detecting intrathecal penetration |
US9358388B2 (en) | 2010-09-30 | 2016-06-07 | Nevro Corporation | Systems and methods for detecting intrathecal penetration |
US10279183B2 (en) | 2010-09-30 | 2019-05-07 | Nevro Corp. | Systems and methods for detecting intrathecal penetration |
US9345891B2 (en) | 2010-09-30 | 2016-05-24 | Nevro Corporation | Systems and methods for positioning implanted devices in a patient |
WO2012044699A2 (en) * | 2010-09-30 | 2012-04-05 | Nevro Corporation | Systems and methods for detecting intrathecal penetration |
US8965482B2 (en) | 2010-09-30 | 2015-02-24 | Nevro Corporation | Systems and methods for positioning implanted devices in a patient |
US11382531B2 (en) | 2010-09-30 | 2022-07-12 | Nevro Corp. | Systems and methods for positioning implanted devices in a patient |
US10076665B2 (en) | 2012-04-02 | 2018-09-18 | Nevro Corp. | Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection |
US9604059B2 (en) | 2012-04-02 | 2017-03-28 | Nevro Corp. | Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection |
US11931577B2 (en) | 2012-04-02 | 2024-03-19 | Nevro Corp. | Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection |
US9002460B2 (en) | 2012-04-02 | 2015-04-07 | Nevro Corporation | Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection |
US8676331B2 (en) | 2012-04-02 | 2014-03-18 | Nevro Corporation | Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection |
RU2509531C1 (en) * | 2012-07-04 | 2014-03-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Тамбовский государственный технический университет" ФГБОУ ВПО ТГТУ | Method for determining bioobject impedance components |
US9409020B2 (en) | 2014-05-20 | 2016-08-09 | Nevro Corporation | Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods |
US11766566B2 (en) | 2014-05-20 | 2023-09-26 | Nevro Corp. | Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods |
US10173062B2 (en) | 2014-05-20 | 2019-01-08 | Nevro Corp. | Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods |
US10881857B2 (en) | 2014-05-20 | 2021-01-05 | Nevro Corp. | Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods |
US11090502B2 (en) | 2014-10-22 | 2021-08-17 | Nevro Corp. | Systems and methods for extending the life of an implanted pulse generator battery |
US9884198B2 (en) | 2014-10-22 | 2018-02-06 | Nevro Corp. | Systems and methods for extending the life of an implanted pulse generator battery |
US9937348B1 (en) | 2015-03-13 | 2018-04-10 | Nevro Corp. | Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator |
US10780276B1 (en) | 2015-03-13 | 2020-09-22 | Nevro Corp. | Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator |
US9517344B1 (en) | 2015-03-13 | 2016-12-13 | Nevro Corporation | Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator |
US10420935B2 (en) | 2015-12-31 | 2019-09-24 | Nevro Corp. | Controller for nerve stimulation circuit and associated systems and methods |
US10980999B2 (en) | 2017-03-09 | 2021-04-20 | Nevro Corp. | Paddle leads and delivery tools, and associated systems and methods |
US11759631B2 (en) | 2017-03-09 | 2023-09-19 | Nevro Corp. | Paddle leads and delivery tools, and associated systems and methods |
RU2669484C1 (en) * | 2017-06-27 | 2018-10-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Тамбовский государственный технический университет" (ФГБОУ ВО "ТГТУ") | Method of determining components of impedance of bio-object |
US11633604B2 (en) | 2018-01-30 | 2023-04-25 | Nevro Corp. | Efficient use of an implantable pulse generator battery, and associated systems and methods |
US11420045B2 (en) | 2018-03-29 | 2022-08-23 | Nevro Corp. | Leads having sidewall openings, and associated systems and methods |
US11571570B2 (en) | 2019-01-31 | 2023-02-07 | Nevro Corp. | Power control circuit for sterilized devices, and associated systems and methods |
US10933238B2 (en) | 2019-01-31 | 2021-03-02 | Nevro Corp. | Power control circuit for sterilized devices, and associated systems and methods |
Also Published As
Publication number | Publication date |
---|---|
US8682447B2 (en) | 2014-03-25 |
US7684869B2 (en) | 2010-03-23 |
US6993384B2 (en) | 2006-01-31 |
US20060122653A1 (en) | 2006-06-08 |
US20060122654A1 (en) | 2006-06-08 |
US20030139781A1 (en) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210205613A1 (en) | Apparatus and method for determining the relative position and orientation of neurostimulation leads | |
US7684869B2 (en) | Apparatus and method for determining the relative position and orientation of neurostimulation leads | |
US10420940B2 (en) | System and method for computationally determining migration of neurostimulation leads | |
US8131358B2 (en) | System and method for maintaining a distribution of currents in an electrode array using independent voltage sources | |
US8972023B2 (en) | Apparatus and methods for detecting position and migration of neurostimulation leads | |
US9089706B2 (en) | Neural stimulation system providing auto adjustment of stimulus output as a function of sensed impedance | |
US9089705B2 (en) | Neurostimulation system with three-dimensional lead migration detection and automatic neurostimulation correction | |
US20130006331A1 (en) | Active Current Control Using the Enclosure of an Implanted Pulse Generator | |
CN105407964A (en) | Systems of providing modulation therapy without perception | |
JP2014012200A (en) | Array stimulator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |